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Abstract 
Intrauterine growth restriction (IUGR) is a pregnancy condition where fetal growth is 
suboptimal, resulting in an infant born small for gestational age (<10th percentile) and is 
associated with metabolic disorders such as type 2 diabetes in adulthood. This study aims to 
understand tissue-specific adaptations to fetal undernutrition which predispose the individual 
to metabolic disorders in adulthood. A model of growth restriction in mice was established 
using 70% of maternal ad libitum total food (g) (E6.5-birth). At weaning, male offspring 
received standard chow or a HFHS diet. Body weight and random blood glucose levels were 
measured at 6 months. To assess metabolism at 6 or 7 months, glucose tolerance, pyruvate 
challenge and hepatic portal vein insulin challenge tests were administered and serum peptide 
markers for obesity and diabetes were measured. Metabolic cages were also used at 2 and 7 
months to measure activity, food intake and respiratory exchange ratios (RERs). Adult liver, 
adipose and skeletal muscle and fetal liver was collected for RNA sequencing. Maternal 
nutrient restricted (MNR) offspring were growth restricted with disproportionately smaller 
fetal livers. 19% of standard chow-fed MNR offspring became glucose intolerant. On an 
isocaloric high-fat high-sugar diet no differences in MNR growth or glucose metabolism 
were detected. However, RERs were reduced at all timepoints in MNR on a HFHS relative to 
MNR on standard chow. Differences in transcription of genes involved in hypoxia signalling 
were detected and HIF-2a and HIF-3a proteins were increased in fetal liver of MNR 
offspring. Genes differentially expressed in the fetus were not differentially expressed at 6 
months. Gene expression of metabolically regulatory transcripts in liver, adipose and skeletal 
muscle did not differ in all MNR and glucose intolerant MNR relative to controls. This 
model results in a susceptible and non-susceptible population of maternal nutrient restricted 
offspring and supports the concept of hypoxia signalling contributing to fetal adaptations. 
Understanding adaptations in hepatic hypoxia signalling in response to fetal undernutrition 
and how they vary in susceptible and unsusceptible populations will provide insight into how 
fetal nutrition can influence adult metabolism. 
Keywords 
growth restriction , glucose tolerance, gene expression, hypoxia, HIF-2a, maternal nutrient 
restriction. 
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Chapter 1 : Introduction 
 Intrauterine Growth Restriction 
Clinically intrauterine growth restriction (IUGR) or fetal growth restriction (FGR) is a 
pregnancy condition where the fetal growth rate is reduced, and the infant is born small 
for gestational age (<10th percentile). Causes can be maternal, fetal or placental. Maternal 
causes include smoking, infections and malnutrition (1). Alternatively, restriction to fetal 
growth can be caused by chromosomal abnormalities in the fetus or insufficient 
development of the placenta (1). Maternal malnutrition and placental insufficiency are the 
most common causes in developing and developed nations, respectively (2). IUGR can 
also be classified into early and late onset. Early-onset IUGR often results in a reduction 
in all organs proportional to body weight and is termed symmetric growth restriction (1). 
Conversely, late-onset IUGR can result in asymmetric growth restriction with 
preservation in brain and heart size at the expense of reductions of less essential organs 
such as the lungs, liver, and kidneys (1). Infants born from pregnancies complicated with 
IUGR are at increased risk for perinatal complications (3) and as adults are more likely to 
develop obesity, glucose intolerance and type II diabetes (4,5). 
 Developmental Origins of Health and Disease 
Studies of populations that were exposed to the Dutch Famine in utero found increased 
occurrence of glucose intolerance and cardiovascular disease (6,7). Since these pivotal 
studies many other studies have demonstrated that pathological reduction in fetal growth 
can influence adult health. Such studies have led to the concept of ‘Developmental 
Origins of Health and Disease’ (DOHaD). In this concept, adversity during fetal 
development and early life can result in adaptations enhancing fetal survival. However, 
these adaptations may not be beneficial to the individual postnatally. For instance, fetal 
nutrient restriction may prime that individual to more efficiently store nutrients. If the 
infant is born into a nutrient-rich environment such as western society, fetal adaptations 
may increase their risk for metabolic disorders. This hypothesis is termed the ‘Thrifty 
Phenotype Hypothesis’(8). 
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 Models of Growth Restriction 
Studies investigating the “Thrifty Phenotype Hypothesis” in human IUGR populations 
are complicated by many confounding variables and ethical limitations. Some of these 
variables can be controlled or adjusted for in the study design or analysis; including 
ethnicity, substance use and socioeconomic status. However, estimating length, extent 
and onset of fetal nutrient restriction can be more challenging.  Additionally, adaptations 
are likely tissue-specific and obtaining fetal and adult samples of metabolically important 
tissues may not be feasible. Due to these challenges, animal models have been developed 
to understand mechanisms underlying IUGR and DOHaD.  
To date, many animal models have been used with different species. Studies in larger 
mammals like pigs are informative due to similarities to humans in physiology, 
morphology and diet (9). However, relatively long lifespans limit outcomes studied to 
early life rather than adulthood. Additionally, these models are costly and will be 
challenging for genetic manipulation to prove the mechanistic importance of altered 
genes. Rodents such as mice are valuable in providing cost-efficient long-term studies, 
with similar genetics and metabolism to humans and the potential for downstream genetic 
manipulation. 
IUGR models in rodents induce growth restriction by various strategies including 
intrauterine artery ligation, hypoxia, lipopolysaccharide (LPS) exposure and maternal 
nutrient restriction. Artery ligation results in decreased nutrient and oxygen delivery to 
the fetus and provides a model of placental insufficiency. However, it is limited to late-
gestation surgeries and results in a higher fetal mortality than controls exposed to sham 
surgeries (10). Recently, a genetic knock out of a transcription factor important in 
trophoblast differentiation, AP-2y,  has also been used to model placental insufficiency 
(11). Maternal exposure to low oxygen chambers results in reduced oxygen delivery to 
the pups similar to a pregnancy at high altitude and LPS-induced growth restriction can 
model IUGR from infections (12,13). Such models can be early to late onset and model a 
specific maternal condition. Maternal nutrient restriction (MNR) also allows a flexible 
onset with some models beginning nutrient restriction prior to conception and others in 
early to late gestation (14–16). Additionally, total calories, or specific micro or macro 
nutrients such as iron or protein can be restricted (15–17). Variations in maternal 
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nutrition can model maternal nutritional challenges experienced in humans such as iron 
deficiencies, inadequate access to protein, or total calorie malnourishment. Additionally, 
total calorie maternal nutrient restriction can be used to model the reduced nutrient 
delivery to the fetus in placental insufficiency. Each type of model is applicable to 
maternal conditions experienced in human pregnancies and are useful to understanding 
how certain adversities affect fetal and long-term health. 
 Fetal Adaptations to Growth Restriction 
Growth restriction models exhibit reduced fetal and birth weight. Reductions in growth 
are symmetric or asymmetric depending on the type and time of insult (18–20). Growth 
restriction has also been associated with hypoglycemia, hypoinsulinemia and increased 
insulin sensitivity in the fetus or young offspring, suggesting an immediate impact on 
fetal glucose metabolism (15,21,22). 
In humans and animal models, reduction in liver size relative to body weight or fractional 
growth rates suggests that the liver is sensitive to fetal nutrition (19,20,23). Reduced liver 
size from maternal nutrient restriction or maternal hypoxia is associated with reduced 
fetal glycogen deposits (24,25) and decreased hepatocyte numbers (26). Increased 
expression of genes in fatty acid oxidation, gluconeogenesis and insulin signalling in 
MNR fetal liver accompany phenotypic changes (27,28). Evidence of increased 
glucocorticoid signalling has also been detected but appears to be specific to the male 
fetus (29).   
In addition to liver adaptations, mice born from nutrient restrictive pregnancies have 
smaller fat mass at birth (30). In total calorie restriction models cultured adipocytes from 
post-natal day 1 have increased hyperplasia, hypertrophy, and increased protein 
expression of lipogenic transcription factors (31). Increased proteins involved in 
glucocorticoid signalling that regulate the mobilization of energy stores are also increased 
in female, but not male, MNR offspring (29). Such adaptations could promote energy 
storage during postnatal development to accommodate for reduced fat stores. 
Skeletal muscle is another metabolically important tissue that is developed into the 
postnatal period, and adaptations in growth restricted offspring include reduced muscle 
mass and fiber type switching. Often growth restricted fetus’ have reduced oxidative type 
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I fibers which are more insulin sensitive (22,32). Some muscle groups like the soleus 
muscle have decreased cross-sectional area of type II fibers relative to controls (32). 
Although myofiber surface area is decreased, the number of myoblasts (progenitor cells 
that can differentiate and fuse to form myotubes) were similar to controls (32). Despite 
maintenance of proliferative capacity when cultured in vitro, myoblasts have reduced 
expression of a proliferation marker (Ki-67) in vivo (32). Regulation of in vivo myoblast 
proliferation and changes in fiber types are influences by protein uptake, blood flow and 
oxygenation which are reduced in muscles, such as the biceps femoris of growth 
restricted fetuses (33). This maintenance of capacity to proliferate could allow the fetus to 
adjust muscle mass if nutrient or oxygen levels are restored during development.  
These tissue-specific fetal adaptations can promote immediate survival. Additionally, 
they could function to predict the postnatal environment in order to enhance survival of 
that offspring to a reproductive age. In the latter case, as described by the “predictive 
adaptive response hypothesis”, these adaptations would be beneficial only if the postnatal 
environment is accurately predicted (34,35). For example, increased insulin sensitivity in 
peripheral tissues can accommodate for hypoinsulinemia due to nutritional scarcity. 
Similarly, reduction in energetically demanding skeletal muscle and an increased 
capacity for proliferation adipocyte proliferation, can promote energy conservation and 
storage. Conserving and storing energy are an advantage in a nutrient restrictive 
environment. However, if the environment proceeding the period of developmental 
placidity does not match that predicted, such as a nutrient abundant one, these changes 
can be maladaptive to long-term health. 
 Changes in Adult offspring in Response to Fetal Growth 
Restriction 
Adaptations in animal models of growth restriction produce changes that influence adult 
metabolism. As adults, offspring are predisposed to glucose intolerance, insulin 
resistance, reduced energy requirement per body weight gain, reduced activity, increased 
appetite and/or increased preferences for fatty foods (16,30,36,37). Although model 
variations exist, male offspring tend to be more prone to changes in glucose metabolism 
and female offspring to adiposity (38,39).  
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Liver-specific changes are in both glucose and lipid metabolism. Increased transcription 
of genes involved in lipogenesis and decrease in proteins involved in cholesterol 
clearance are associated with steatosis in offspring from fetal undernutrition (20,40). 
Glycogen deposits are also increased in adult offspring from growth restricted 
pregnancies (41). In normal tissues, insulin receptor activation by binding of insulin 
results in increases IRS-2 and Akt phosphorylation, which increase glucose uptake and 
glycogen synthesis and prevent hepatic glucose output. However, in IUGR rats from 
placental insufficiency insulin stimulation does not result in increased phosphorylation of 
IRS-2 or AKT or suppression of hepatic glucose production (42). Although increased free 
fatty acids (FFAs) can contribute to hepatic insulin resistance, insulin resistance has been 
detected in the absence of dyslipidemia (42). These data suggest that fetal undernutrition 
results in offspring with insulin desensitization and an aberrant energy balance in the 
liver that favors storage of lipids and glycogen. 
Adult offspring also have changes in adipocyte size, number and/or growth. Increased 
percent body fat has been observed with and without changes in body weight (20,43). 
Offspring from 50 % maternal nutrient restriction late in gestation have increased 
lipogenic gene expression and increased adipocyte size (44). Conversely, moderate 
maternal nutrient restriction throughout pregnancy is associated with an increased 
number but smaller adipocytes in female offspring (38). Decreased insulin sensitivity can 
also occur in adipose tissue when growth restriction extends into lactation, but impact 
males rather than females (39). Enhanced growth and inflammation in adipose tissue can 
also influence differences in body mass and insulin sensitivity (30). Such studies suggest 
that fetal adaptations to undernutrition can influence adult body mass composition, and 
glucose and lipid metabolism in a sex-specific and model-specific manner.  
Changes in body composition are also associated with reduced lean mass. Similar to the 
growth restricted fetus, reduced muscle area and type I fiber number can persist into 
adulthood (45,46). Premature aging by telomere shortening and DNA damage has also 
been observed in the vastus lateralis muscle of aged prenatal protein restricted rats (47). 
Decreased p-AKT to AKT ratios in response to insulin have also been observed in adult 
male offspring from maternal protein restriction, suggesting impaired insulin sensitivity 
in skeletal muscle (39). Reduced mass, insulin sensitivity and aging in skeletal muscle 
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could contribute to aberrant glucose tolerance, reduced lean mass and insulin resistance 
in adult offspring, increasing risk metabolic disorders. 
 Growth Restriction and Postnatal Diets 
Adaptations in growth restricted offspring can impact responses to stress. High caloric, 
high-fat (HFD) or high-fat high-sugar (HFHS) diets in animal models can mimic the 
‘western diet’, a calorie dense diet that is high in saturated fat and refined sugars. Such 
diets, in combination with fetal changes to conserved energy due to fetal undernutrition, 
lead to further dysfunction in glucose and lipid metabolism and behavior. Growth 
restricted offspring are more susceptible to diet-induced obesity and adipose tissue 
inflammation (30). In part, due to increased lipogenesis in adipose tissue and decreased 
cholesterol clearance in the liver, which leads to ectopic lipid accumulation and increase 
serum lipids (31,48–50). Both ectopic lipids and serum FFAs are associated with 
decreased insulin sensitivity (51). Although sedentary behavior is observed in some 
models of IUGR, postnatal HFD diets can further reduce activity in offspring(16). These 
studies suggest that growth restricted offspring are maladapted to a nutrient abundant 
diet. 
 Hypoxia Signalling 
One pathway activated in response to cellular stress such as low oxygen or nutrient over 
or under abundance, is hypoxia-inducible factor (HIF) signalling. In physiologically 
normal oxygen tension, oxygen is available for prolyl hydroxylases (PHDs) to 
hydroxylate the oxygen degradation domain (ODD) of the a subunit (HIF-1, 2 or 3 a) 
(52). Hydroxylation to the ODD of the a subunit allows recognition by the pVHL-
containing ubiquitin ligase and degradation by the proteasome (53). In the absence of 
oxygen, the unhydroxylated a subunit can dimerize with HIF-1b. The HIF dimer can 
then translocate to the nucleus and transcriptionally regulate genes containing hypoxic 
response elements (HREs) (54) (Figure 1.4.1) . In addition to PHD hydroxylation, HIFa 
stability and transcriptional activity can be modulated by phosphorylation, hydroxylation, 
and ribosylation in the ODD, C-terminal and N-terminal transactivation domains (C-
TAD, T-TAD) which are regulated by oxygen and nutrient availability (17,53,55). HRE-
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containing genes are involved in pathways important in stress response as well as normal 
development including metabolism, angiogenesis, proliferation and apoptosis (54). 
 
Figure 1.4.1 Regulation of HIF Alpha Subunits in Hypoxia and Normoxic 
Conditions. 
Under normoxic conditions, the alpha subunit is hydroxylated by PHDs in the oxygen 
degradation domain, resulting in recognition and degradation by the proteasome. In 
hypoxia, oxygen is not available for hydroxylation and the alpha subunits are stabilized. 
Stable alpha subunits can dimerize with the beta subunit, translocate to the nucleus, and 
regulate expression of genes containing hypoxia response elements (HRE). 
 Hypoxia Signalling in Animal Models 
Maternal hypoxia has been well documented to cause fetal growth restriction but recent 
evidence suggests that other models of growth restriction can lead to hypoxic signalling 
in placental or fetal tissues (56-58). Maternal nutrients and maternal protein restriction 
result in placental adaptations that could decrease oxygen delivery to fetal tissues and 
directly cause fetal hypoxia. In mice, the placenta can be divided into two functional 
zones, the junctional and labyrinth zone. The junctional zone is involved in endocrine 
signalling and energy storage and the labyrinth zone is the site of oxygen and nutrient 
exchange. In growth restricted models, the zone most often impacted is the junctional 
zone (59). Additionally, the placental weight relative to fetal weight ratio is increased and 
oxygen tension was not different in growth restricted placentas (56). Availability of 
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nutrients is known to modulate hypoxia signalling in vitro. In addition to oxygen, iron is 
required for PHD hydroxylation of the HIFa subunits. Pathways in nutrient sensing, such 
as GSK-3b, have also been implicated in regulation of a subunit stability or activity 
(53,57). Together these data suggest that fetal nutrition may mediate hypoxic signalling 
through redistribution of fetal circulation and nutrient signalling pathways and could 
potentiate fetal adaptations to growth restriction. 
 Hypoxia Signalling in Pregnancies Complicated with 
IUGR 
Evidence of increased hypoxia-inducible signalling is present in placentas from IUGR 
with preeclampsia, however, induction of this pathway in pregnancies with IUGR only 
are inconsistent across studies (55,60). Similar to animal models of growth restriction, 
some placentas from intrauterine growth restriction exhibit no changes in HIF proteins 
(62). Whether hypoxia signalling may be induced in developing fetal tissues in human 
IUGR pregnancies is currently unknown. It is possible that HIFs are differentially 
regulating development or organ function, influencing perinatal and adult health. 
 Thesis Rationale 
In this study we aimed to identify transcriptional changes that are associated with fetal 
adaptations and/or changes in adult glucose metabolism in offspring from maternal 
nutrient restriction (MNR) (70% ad libitum food) in mice, and how the postnatal diet may 
modulate these changes. To isolate fetal undernutrition to pregnancy, without having an 
impact on litter size or postnatal nutrition, maternal food restriction was applied post-
implantation (E6.5) until birth and all litters were cross-fostered to ad libitum fed 
mothers. Unpublished work from our lab has shown that male, but not female, offspring 
develop glucose intolerance at 6 months of age. Despite detection of glucose intolerance, 
there was no difference in serum insulin which suggests peripheral insulin desensitization 
rather than insulin deficiency. Additionally, other models have shown males are 
vulnerable to changes in insulin sensitivity of peripheral tissues (39). Subsequently, male 
offspring were the focus in this study. The liver, adipose tissue and skeletal muscle are 
metabolically important peripheral tissues that have been impacted in other models of 
growth restriction (39,42) and could mediate long-term changes in glucose tolerance. To 
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this end, fetal and adult liver, as well as skeletal muscle and visceral adipose tissue in 
adults were assessed for changes in gene expression. This study is also unique because 
adult organs collected for gene expression analysis are from mice that underwent 
metabolic testing. Knowledge of the metabolic status for each mouse could aid in 
identifying relevant transcription changes to the biological outcome. While other models 
exist to study these tissues in nutrient restricted animals, most are in rats, guinea pigs and 
larger mammals (22,37,63). A mouse model will allow further studies to genetically 
manipulate identified genes and determine the role in fetal survival or offspring glucose 
metabolism. Understanding the mechanism underlying associations between fetal 
nutrition, growth restriction and adult metabolism will assist in identifying and treating 
IUGR most at risk for adult metabolic disorders.   
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 Hypothesis and Objectives 
Hypotheses: Changes in expression of genes regulating metabolism or tissue development 
in liver, adipose and/or skeletal muscle occur in response to fetal nutrient restriction and 
contribute to an altered adult glucose metabolism. We also hypothesized that a HFHS 
will amplify the changes in metabolism in maternal nutrient restricted (MNR) offspring. 
Objective 1: Metabolically assess outcomes of maternal nutrient restriction in adult 
offspring. 
Aim one: Characterize the impact of MNR on offspring adult glucose metabolism 
when maintained on a standard diet chow post-weaning. 
Aim two: Determine the effects of fetal undernutrition with a post-weaning high-
fat high-sugar (HFHS) diet in adult offspring. 
Objective 2: Identify transcripts differentially expressed throughout the life of MNR 
offspring in metabolically important tissues. 
Aim one: Determine whether differential expression of genes regulating 
metabolism or tissue development occurred in E18.5 liver in response to MNR. 
Aim two: Assess differential expression of genes regulating glucose metabolism in 
adult liver, skeletal muscle and adipose tissue. 
Objective 3: Evaluate protein levels of differentially expressed genes involved in hypoxia 
signalling in fetal liver.   
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 Introduction 
Fetal growth restriction (FGR) or intrauterine growth restriction (IUGR) is a pregnancy 
condition where the fetus fails to achieve optimal growth expected for gestational age 
resulting in a small for gestational age (SGA) newborn with birth weight of <10th 
percentile. The most common causes include maternal malnutrition in developing 
countries and placental insufficiency in developed countries (1). Irrespective of the cause, 
poor macro- and micro-nutrient and substrate concentrations in the fetus are a common 
pathophysiological finding. Growth restricted infants are at increased risk for morbidity 
and mortality in the perinatal period (2). As adults IUGR populations are also at 
increased risk for chronic diseases including cardiovascular diseases (3), metabolic 
disorders such as type 2 diabetes and glucose intolerance (3), and obesity and abnormal 
lipid metabolism (4). 
 
Associations between poor fetal growth and adult health and disease have led to the 
concept of Developmental Origins of Health and Disease (DOHaD). The theory of 
DOHaD proposes that environmental exposures, such as nutrient restriction, during 
development can result in metabolic adaptations that enhance the survival of the fetus but 
increase the risk for metabolic disorders as children and adults (5). The concept 
underlying the association between poor fetal nutrition and predisposition to adult 
diseases is termed the “thrifty phenotype hypothesis”(5). 
 
Fetal growth restriction has been studied using maternal nutrient restriction in animals 
such as rats (6–8) and guinea pigs (9), or larger mammals like pigs (10,11). These models 
providing a short lifespan or similar morphology and diet to humans, respectively, and 
insight into long and short-term changes in IUGR offspring. Genetic manipulation in 
offspring to identify genes and epigenetic changes moderating impacts of fetal nutrition 
are limited. Such limitations can be addressed by using maternal nutrient restriction in 
mice.  
 
Models of growth restriction in rodents by manipulating maternal nutrition provide 
insight into certain types of fetal undernutrition in humans, either due to the onset of 
placental insufficiency or food availability. For example, nutrient restriction prior to and 
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throughout pregnancy in rodents (9,12) model mothers that experience extended 
nutritional deficits. However, these models would not mimic fetal undernutrition due to 
placental insufficiency. Conversely, nutrient restriction beginning later in gestation may 
imitate insufficient placental development (6). Nutrient restriction just after implantation 
in the mouse at E6.5 has not been studied and would be more similar to early- to mid-
gestation-onset placental insufficiency.  
 
Evidence suggests that metabolic adaptions to fetal undernutrition are tissue-specific and 
serum peptides for obesity and diabetes can aid in identification of impacted tissues. 
Incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent 
insulinotropic peptide (GIP), are released by the gut upon ingestion of food and stimulate 
release of insulin (13,14). Insulin and glucagon are pancreatic hormones that regulate 
tissue glucose uptake and energy utilization. In addition to hormone release, c-peptide, 
the cleaved portion of proinsulin, can indicate changes in insulin maturation (15). Leptin, 
resistin (16) and plasminogen activator inhibitor (PAI-1) (17) are secreted primarily from 
adipose tissue in mice. Leptin and ghrelin, which is released from the gut, regulate 
appetite (18,19). Changes in these markers in addition to other metabolic tests can 
provide insight into tissues with metabolic adaptations. 
 
The objective of this study was to establish a moderate total calorie nutrient restriction in 
mice to mimic human FGR populations and examine the long-term metabolic 
complications. We hypothesized that a 30% reduction in maternal food consumption by 
weight during early and late pregnancy would result in reduced fetal and newborn weight 
and tissue-specific alterations in adult glucose metabolism similar to humans. 
 Methods 
 Animals 
The animal experiments were conducted as approved by the Council on Animal Care at 
the University of Western Ontario. All mice received free access to water in a standard 12 
h light/dark cycle. Eight-week-old virgin female CD-1 mice, obtained from Charles River 
Laboratories (Montreal, PQ, Canada), were mated. The presence of mucous plugs 
indicated E0.5. After mating mice were housed individually. To avoid reduction in the 
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number of conceptuses of each litter, mated females received ad libitum food until after 
embryo implantation at about E5. At E6.5, the mice were randomly assigned into two 
groups, the control group was fed ad libitum and the maternal nutrient restriction (MNR) 
group was fed 70% average ad libitum total calorie intake (both groups receiving #F0173, 
Bio-Serv, Flemington, NJ). At E18.5, 3 control and 3 MNR pregnant females were 
euthanized by CO2 narcosis. No differences between the number of males and females 
were observed between MNR and control litters (Supplementary Table 2.2.1).  Litter 
size ranged from 6 to 22 pups. To control for variations in litter size only litters with 11-
15 pups were analyzed in fetal (Control litters = 3, MNR litters = 3) and long-term 
studies (Control litters = 5, MNR litters =10). Because many studies suggest that male 
offspring are more sensitive to maternal undernutrition (20–22) and that post-
reproductive changes complicate long term studies in females (23), only males were 
examines in this study. PCR of the SRY gene, which is located on the y chromosome and 
is important in sex determination in mice, (forward primer - 
TGGACTGGTGACAARGCTA, reverse primer - TGGAAGTACAGGTGTGCACTCT) 
was used in fetal studies to include males only (Control N=21, MNR=15). Right liver 
lobes were snap frozen in liquid nitrogen.  
 
For postnatal studies, pups’ paws were tattooed at birth to track weights for each pup with 
the Armis Microtatoo kit (Braintree Scientific, Inc., Braintree, MA). To assess impacts of 
reduced nutrition during fetal development without the influence of nutrition during 
lactation, all litters were cross-fostered to females that were fed ad libitum throughout 
pregnancy and the litters were culled or fostered to 13 pups each. Since MNR resulted in 
similar male-to-female ratios to control litters, the sex of pups was selected randomly 
(Supplementary Table 2.2.1). Ad libitum standard chow (Teklad LM-485 Mouse/Rat 
Serializable Diet, Mississauga, ON, Canada) was used for the remainder of the study in 
both MNR and control offspring . 
 
At weaning (P21) only male offspring were kept for further study (Control litters N=5, 
MNR litters N=10) and were housed with 3 to 5 siblings per cage (Figure 2.2.1) Weight 
was measured once a month. With the exception of littermates used for the intrahepatic 
portal vein insulin challenge, offspring at 1 month (control N=12, MNR N=19, 1-2 pups 
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per litter) and 6 months (control N=30, MNR N=52, all remaining pups) were euthanized 
with CO2 narcosis. Weight was measured and serum was collected via intracardiac 
puncture. Individual liver lobes, perigonadal adipose tissue, and quadriceps femoris were 
collected, snap frozen in liquid nitrogen, and stored at -80°C until analysis. Seven-month 
old animals used for the intrahepatic portal vein insulin challenge (N=8 per group) and 
were euthanized after tissue collections. 
 Glucose Tolerance and Hepatic Glucose Production 
Glucose tolerance was assessed in 36 MNR (10 litters) and 25 controls (5 litters, 3-8 
pups/litter) one week prior to tissue collections or pyruvate challenge test at 6 months by 
intraperitoneal glucose tolerance testing (IP-GTT). Briefly, fasted mice (4 h) (at 8 00 am) 
were injected with glucose 2 g/kg body weight and blood glucose was measured via tail 
vein every 30 minutes for 2 h using a Freestyle Lite Glucometer (Abbott, Alameda, CA). 
At 6 months, hepatic glucose output was measured with a pyruvate challenge test (5 pups 
per group, 1 pup/litter). Pyruvate was injected (IP) into mice fasted for 4 h (at 8 00 am) at 
2 g/kg body weight and blood glucose was measured via tail vein every 30 min for 2 h. 
 Random Blood Glucose 
From 1 to 6 months, monthly random blood glucose (non-fasted) was measured. Blood 
samples were collected at 10:30 am via tail vein prick and measured using a Freestyle 
Lite Glucometer (Abbott, Alameda, CA). 
 Intrahepatic Portal Vein Insulin Challenge Test 
Seven months-old mice were fasted for 4 hours and anaesthetized with isoflurane. Insulin 
stock was diluted 100X into sterile saline (Humalin R, Eli Lilly Canada Inc., Toronto, 
ON Canada, 100U/mL). Using a mid-line incision, intestines were moved to expose the 
hepatic portal vein and 2 U/kg of insulin  (Control and MNR N=5, 1 pup/litter) or saline 
(Control and MNR N=3, 1 pup/litter) was injected. After 1 minute and 15 seconds, a 
piece of right medial liver lobe, a quadriceps femoris muscle and perigonadal fat were 
frozen in liquid nitrogen. Samples were store in -80°C until western blot analysis (24). 
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 Protein Isolation 
Fifty mg of frozen liver and muscle and 100 mg of adipose tissue were pulverized 
(Medium Bessman Tissue Pulverizer, Spectrum Laboratories, Rancho Dominguez, CA) 
and then homogenized for 30 seconds with the Brinkmann Homogenizer Polytron® 3000 
in 1x Cell Lysis Buffer (9803S, Cell Signaling Technology® Inc., Danvers, MA) and 
protease inhibitor cocktail 1, 2, and 3 (P1860, P5726, and P0044, Sigma-Aldrich, St. 
Louis, MO, USA). The homogenate was then sonicated (F550 Sonic Dismemberator, 
Fisher Scientific, Markham, ON Canada) and rocked for 40 minutes at 4°C. Samples 
were spun at 12,000 x g for 10 minutes at 4°C. Supernatants were collected, with care not 
to collect the lipid layer, and stored at -20°C until analysis. Protein quantification was 
done with the Bio-Rad Protein Assay according to the manufacturer’s protocol using 
BSA standards (Cat #500-0006, Bio-Rad Laboratories Inc., Des Plaines, IL). 
 Western Blotting 
Protein samples were boiled in sodium dodecyl sulfate (SDS) sample loading buffer with 
0.1M dithiothreitol (DTT) at 75 °C for 5 min then incubated on ice for 5 minutes. 10 μg 
of protein was loaded and run on a 10% SDS polyacrylamide gel. Proteins were 
transferred to a polyvinylidene difluoride (PVDF) membrane using the Trans-Blot® 
Turbo™ Transfer System and Trans-Blot® Turbo™ RTA Midi Transfer Kit (170-4273, 
Bio-Rad Laboratories Inc., Des Plaines, IL) according to the manufacturer’s protocol. 
 
Once the transfer was completed, membranes were dipped in methanol and blocked with 
5% milk in TBST (TBS + 1 % tween). Blocking buffer was rinsed from the membrane 
for 5 min (3x) with TBST at room temperature (RT). Primary antibody for p-AKT 
(#4000, rabbit mAB, Cell Signaling Technology® Inc.) was diluted 1:1000 into 5% BSA 
in TBST and incubated with blots shaking at overnight at 4°C. Membranes were rinsed 
with TBST 3 x (5 min.) at RT and then incubated with secondary rabbit IgG (#170-6515, 
Bio-Rad Laboratories Inc., Des Plaines, IL) diluted 1:10,000 in 5% milk in TBST for 1 
hour at RT. After rinsing the secondary antibody, ClarityTM Western ECL Substrate (170-
5061, Bio-Rad Laboratories Inc., Des Plaines, IL) and a VersaDoc Imaging System (Bio-
Rad Laboratories Inc., Des Plaines, IL), was used to capture an image of the gel. 
Membranes were then rinsed and stripped with 0.5M NaOH, rinsed in TBS (3 x 5 min at 
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RT) and reprobed with AKT (#9272, Bio-Rad Laboratories Inc., Des Plaines, IL), 
according to the protocol above.  
 
Quantification of blots was done using Imagelab software® version 5.1 BETA (Bio-Rad 
Laboratories Inc., Des Plaines, IL) and quantities were compared using p-AKT to total 
AKT ratios. 
 Serum Peptide Markers for Obesity and Diabetes 
Blood samples collected by intracardiac puncture at 1 (Control N=7, MNR N=18, 4 
control and 10 MNR litters, 1-2 pups/litter) and 6 months (5 control and 10 MNR litters, 
3-7 pups/litter, MNR N=52, control N= 30) in non-fasted mice (8 30 - 9 30 h) were used 
in this multiplex assay. At the time of collection, protease inhibitors, 10mM DPP-IV 
(EMD Millipore, DPP4-010) and 1.3% aprotinin inhibitor (EMD Millipore, 616399) in 
0.9% sterile saline, were added to the blood samples (10uL/mL). Samples were allowed 
to clot for 45 minutes and spun at twice at 12 000 x g for 10 minutes to obtain serum. All 
serum samples were stored at -80°C. Ghrelin, leptin, insulin, glucagon, PAI-1, GLP, GIP 
and resistin were assayed on the Bio-rad Multiplex at Lawson’s Multiplex Facility, 
London, ON, using the Bio-Plex Pro Mouse Diabetes Assay (171F7001M, Bio-Rad 
Laboratories Inc., Des Plaines, IL). Serum C-peptide was also quantified according to the 
manufacturer’s protocol (Mouse C-Peptide ELISA, 80-CPTMA-E1, Alpco, Salem, NH). 
 Lipid Quantification in Serum and Liver 
An aliquot of non-fasted serum as described above was used to for cholesterol 
(Cholesterol Quantification Kit MAK043, Sigma-Aldrich®, St. Louis, MO) and 
triglyceride quantification (Triglyceride Quantification Assay Kit ab65336, Abcam®, 
Cambridge MA). Liver cholesterol was also isolated from non-fasted liver tissue and 
quantified according the manufacturer’s protocol. Measurements were taken from 5 
control and 10 MNR litters, 3-6 pups/litter. 
 Statistical Analysis 
Data are presented as mean ± SEM or as whisker plots (median and data range in 
quartiles). For glucose tolerance testing, pyruvate challenge tests and random blood 
glucose measurements a repeated measures ANOVA and Bonferroni post hoc correction 
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was used. For all other analyses, a Mann-Whitney test was used to compare means where 
samples sizes were > 8, and an unpaired t-test with £ 8 samples. Means are considered 
significantly different if p < 0.05. All statistics and graphs were produced in Prism 
software (Graphpad®, version 5.2), or the R console (version 3.3.2) with ggplot2 (version 
2.2.1) and sciplot (version 1.1-0) software packages. 
 
 
Figure 2.2.1 Litter and Pup Sample Size for Postnatal Studies. 
 Results 
Maternal total-calorie nutrient restriction (MNR) resulted in a 13% reduction (p = 0.001) 
in fetal weight at E18.5 in males (Figure 2.3.1A), and 14% reduction (p = 1.5 x 10-8) in 
birth weight of males (Figure 2.3.1B), relative to controls. E18.5 weight did not vary 
significantly with position relative to blood supply (p = 0.4) (Supplementary Figure 
S2.3.1). Body weights are not significantly different in MNR offspring between day 3 of 
life and 6 months (Figure 2.3.1C), except at 1 month (p = 0.006) when controls (23.5 ± 
0.4 g) were heavier than MNR (22.3 ± 0.3 g). This protocol demonstrated a reproducible 
fetal growth restriction from moderate maternal nutrient restriction. 
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In addition to body weight, organ weights were measured at each dissection. Fetal liver-
to-body weight ratio was 1.4-fold reduced in MNR offspring (0.05 ± 0.003) relative to 
controls (0.07 ± 0.002, p < 0.0001), indicating a disproportionate effect of maternal 
nutrition on the liver (Figure 2.3.2A). All other organs were proportionally reduced with 
body weight. At one-month liver weight relative to body weight was similar in MNR 
offspring (0.053 ± 0.005) (p = 0.09) (Figure 2.3.2B) but decreased again by 6 months 
(0.039 ± 0.004) (p = 0.03) compared to controls (0.057 ± 0.008 and 0.042 ± 0.006, at 1 
and 6 months respectively). The disproportionate impact on the liver growth suggests the 
effects of fetal nutrition extend into adulthood (Figure 2.3.2C). 
 
Whole body glucose metabolism and hepatic glucose output was assessed with IP-GTT 
and pyruvate challenge tests, respectively. Reduced AUC in 6-month-old MNR offspring 
(1553 +/- 57) relative to controls (1323 +/- 68, p = 0.045) demonstrated impaired glucose 
tolerance (Figure 2.3.3A and B). Fasting blood glucose at the time of GTT did not differ 
in MNR offspring (p = 0.3) (Figure 2.3.3A). Blood glucose at all time points and the 
AUC for pyruvate challenge testing (Supplementary Figure S2.3.2) indicated similar 
hepatic glucose output in MNR offspring relative to controls. Therefore, moderate 
differences in glucose metabolism were detected in the MNR offspring. 
 
Random blood glucose was measured once a month until 6 months of age. MNR 
offspring had similar blood glucose to controls each month (p = 0.4) and the AUC did not 
differ (p = 0.3) (Figure 2.3.4). 
 
Serum peptide markers for diabetes and obesity were also assayed at one and six months 
of age. At one month, PAI-1 was 1.9-fold higher in MNR offspring relative to controls (p 
= 0.04) (Figure 2.3.5A i). PAI-1 remained higher in six-month MNR offspring (1.5-fold) 
(p = 0.04) (Figure 2.3.5B i). Increased resistin was also detected at 6 months in MNR 
offspring (189.8  + 9.8 ng/mL) relative to controls (171.2 + 14.5 ng/mL, p = 0.04) 
(Figure 2.3.5B v). C-peptide, insulin-to-glucagon ratio, GIP, GLP, ghrelin and leptin did 
not differ based on maternal nutrition at one and six months (Figure 2.3.5). 
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In addition to peptide markers, lipids were measured in serum and the right lateral liver 
lobe at 6 months. No differences were observed between control and nutrient restricted 
offspring in serum triglycerides (p = 0.6) (Figure 2.3.6 Ai) or total cholesterol (p = 0.7) 
(Figure 2.3.6 Aii). Additionally, control and MNR offspring had a similar liver 
cholesterol (p = 0.07) (Figure 2.3.6 B). 
 
A hepatic portal vein insulin challenge was used to examine tissue-specific insulin 
sensitivity. Relative to controls, the p-AKT to AKT ratio was increased 2.5-fold in the 
liver of MNR offspring in response to the insulin injection (p = 0.004) (Figure 2.3.7A). 
Although not significant, insulin stimulated phosphorylation of AKT in adipose tissue 
(Figure 2.3.7B) and skeletal muscle (Figure 2.3.7C) was not significantly different in the 
nutrient restricted offspring, respectively (p = 0.08 and 0.05 respectively). 
 
While changes in glucose metabolism occurred to some extent in all MNR offspring, 
there was a variation in the degree of response to fetal nutrient restriction on adult 
glucose metabolism. At 6 months, 19% of the offspring were less tolerant to glucose 
(Figure 2.3.8A) and had a higher AUC than any controls (Figure 2.3.8B). The remaining 
MNR have AUCs that were similar to those of controls.  
 
Serum peptide analysis in the less tolerant mice showed increased insulin (p = 0.006), 
leptin (p = 0.001) (Figure 2.3.9G), and resistin (p = 0.005) (Figure 2.3.9F) levels, with 
no changes in other assayed peptide markers (Figure 2.3.9).  
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Figure 2.3.1 Body weights of MNR and Control offspring from E18.5 until 6 
months. 
At E18.5, fetal weights of MNR (N=15) were 13% smaller than controls (N=20) (p = 
0.001) (3 Control and 3 MNR litters, 3-8 pups per litter) (a). Birth weight of MNR 
offspring remained 14% smaller (p = 1.5 x 10-8) (Control N=39 from 5 litters, MNR 
N=58 from 10 litters, 4-9 pups/litter) (b). Except at 1 month when controls were heavier 
than MNR (p = 0.005), no differences were observed in weight from day 3 to 6 months. 
From birth-1-month, Control N= 37 and MNR N= 52 from 5 control and 10 MNR litters 
(3-11 pups/litter). From 2 months-6 months, Control N= 27 and MNR N=36 from 5 
control and 10 MNR litters (3-9 pups/litter) (c). Growth curve data is plotted as the mean 
+ SEM. Asterisk represents significance (p < 0.05) with a Mann-Whitney test.  
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Figure 2.3.2 Organ weights of male offspring at E18.5, 1 month and 6 months. 
 (a) At E18.5, liver weight was reduced in MNR offspring relative to their body weight (p 
< 0.0001) (Control N=20 and MNR N=15, 3 litters/group, 3-8 pups/litter). (b) Relative to 
body weight the liver of MNR offspring was similar to controls at 1 month (p = 0.09) 
(control N=12 from 5 litters, MNR N=19, 9 litters, 1-3 pups/litter) and significantly lower 
at 6 months (p = 0.03) (control N= 24, MNR N=30, 5 control and 10 MNR Litters, 3-8 
pups/litter). (c). Fetal data are mean + SEM (a). Asterisk represents a p < 0.05 with a 
Mann-Whitney test.  
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Figure 2.3.3 IP-GTT of male offspring at 6 months. 
Blood glucose at 90 and 120 minutes were significantly higher in MNR offspring (N=36, 
10 litters) relative to controls (N= 25, 5 litters, 3-8 pups/litter) (a). The AUC was also 
significantly higher (p = 0.045) (b). Glucose tolerance data (a) are mean + SEM. Asterisk 
represents a p < 0.05 with a Bonferroni post hoc (a) or Mann-Whitney test (b).
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Figure 2.3.4 Random blood glucose in male MNR and control offspring from 1 to 6 
months of age. 
 (A) Random blood glucose did not significantly differ at age. (B) AUC from random 
blood glucose was similar between MNR and control indicating normoglycemia in MNR 
offspring. At 1 month Control N= 33, MNR N= 51 (5 control and 10 MNR litters, 3-11 
pups/litter); from 2 months-6 months Control N= 26, MNR N=36 (5 control and 10 MNR 
litters, 3-9 pups/litter). Data are mean + SEM (a) or whisker plots (b). Asterisk represents 
a p < 0.05 with a repeated measures ANOVA(a) or Mann-Whitney test(b).  
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Figure 2.3.5 Serum peptide markers for obesity and diabetes. 
Peptides were measured at (a) 1 month (Control N=7, MNR N=18, 4 control and 10 
MNR litters, 1-2 pups/litter), and (b) 6 months of age (5 control and 10 MNR litters, 3-7 
pups/litter, MNR N=52, control N= 30). PAI-1 was increased in MNR offspring at 1 
month (p = 0.04) and 6 months (p = 0.04), (i) and resistin at 6 months (p = 0.04) (v). 
Ghrelin (ii), GLP-1 (iii), leptin (iv), GIP (vi), insulin to glucagon ratios (vii), and C-
peptide (viii) levels were similar between control and MNR offspring. Data are presented 
as the median and quartiles in whisker plots. Asterisk indicates a p < 0.05 with a Mann-
Whitney test.
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Figure 2.3.6 Serum and liver lipids in male MNR (N=36) and control (N=27) 
offspring at 6 months of age. 
A. Serum triglyceride (p = 0.6) (i) and total cholesterol (ii) (p = 0.7) were not 
significantly different between MNR and control offspring. B. Liver total cholesterol was 
also similar between MNR and control offspring (p = 0.07). 5 control and 10 MNR 
litters, 3-6 pups/litter. Data are mean + SEM (a). Asterisk represents a p < 0.05 with a 
Mann-Whitney test. 
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35 
Figure 2.3.7 Insulin signalling as determined by phosphorylation of AKT in 
response to an insulin bolus in male MNR and control offspring at 7 months of age. 
p-Akt relative to AKT after an insulin dose was increased in MNR offspring relative to 
controls in the right medial liver lobe (p = 0.004) (a). p-AKT to AKT ratios were 
relatively increased in MNR adipose tissue and (b) skeletal muscle of insulin injected 
mice, but this change was not significant (p = 0.08 and 0.05, respectively) (c). Saline 
injected N=3 and insulin injected N=5 for both maternal nutrition groups (5 control and 8 
MNR litters, 1 pup/litter). Western blots were done in quadruplicates. A representative 
blot and quantification of the replicates are shown with whisker plots. Means with 
different letters are significantly different (p < 0.05, unpaired t-test).  
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Figure 2.3.8 Glucose tolerance tests for all MNR and control offspring at 6 months. 
(a) Individual glucose tolerance tests for controls demonstrate the range of responses. (b) 
7 MNR (black) had an AUC under the curve greater than other MNR or controls (grey) 
(c) which are referred to as intolerant MNR (5 control and 10 MNR litters, 3-8 
pups/litter).   
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Figure 2.3.9 Serum peptide markers for obesity and diabetes in male MNR and 
control offspring at 6 months old according to glucose tolerance. 
Resistin (p = 0.005) (d) and leptin (p = 0.001) (e) were significantly increased in MNR 
offspring that are glucose intolerant. PAI-1 (a), Ghrelin (b), GLP-1(c), GIP(f), 
insulin:glucagon (g) and c-peptide (h) were not significantly different in intolerant MNR. 
Control N=30 (5 litters, 3-8 pups/litter), tolerant MNR N=43 (10 litters, 3-8 pups/litter) 
and intolerant MNR N=7 (5 litters, 1-2 pups/litter). Asterisk represents a p < 0.05 with a 
Mann-Whitney test.  
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 Discussion 
In humans, FGR can be symmetric or asymmetric. Symmetric FGR, meaning all organs 
are reduced proportionately to body weight, is often associated with an insult of early-
onset (25). Conversely, asymmetric FGR is more common in late-onset growth 
restriction, and is where less essential organs are reduced but vital organs such as the 
brain and the heart are spared (25). Similar to humans, maternal undernutrition in mice 
resulted in an asymmetric growth restriction and had the most significant impact on the 
liver (26). The thymus and spleen are also smaller relative to body weight in SGA 
autopsies (26) but were not measured in this study. Although reduced again at 6 months, 
one-month relative liver weights were similar to controls which might indicate 
differences in growth rate of the liver in MNR offspring. MNR in guinea pigs do not 
result in reduced liver-to-fetal weight ratios but fractional growth rates are increased near 
term (9). These data suggest that liver growth may be more sensitive than other organs to 
fetal undernutrition. 
 
The variation in response to fetal nutrient restriction in our model was similar to the 
variations observed in the human FGR populations. Some individuals with extremely low 
birth weights (ELBW) although having 3 times greater risk will not develop glucose 
intolerance and type 2 diabetes(3). In adults, genetic variation and differential expression 
contribute to obesity and metabolic disorder resistant and/or susceptible populations of 
non-human primate (27) and rodent models (28,29) in response to nutritional stress, such 
as a high fat diet. Offspring in models exposed to a maternal high fat diet or nutrient 
restriction have metabolic (7,30), gut microbe (31) and epigenomic changes (32), but to 
our knowledge none of these models focus on changes specific to susceptible and 
resistant populations in these offspring. Having glucose tolerant and intolerant offspring 
resulting from MNR allow future studies to examine adaptations in glucose metabolism 
within the MNR populations and in all offspring exposed to nutrient restriction in utero. 
 
In this study, normal glucose tolerance observed in 81% of the offspring might have been 
due to increased insulin sensitivity as adults despite having smaller livers. Increased 
insulin sensitivity is present at birth and persists a few weeks postnatally in lambs 
exposed to hypoxia-induced placental insufficiency (33). To our knowledge, evidence of 
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insulin desensitization (6,7) has been observed rather than persistence of the increased 
sensitivity into adulthood. Intolerant MNR offspring, which had relatively higher insulin-
to-glucagon ratios, could have insulin resistance that was not detectable during insulin 
sensitivity test due to the limited sample size. Studies comparing liver responses in 
intolerant and tolerant MNR mice may provide insight into why some offspring are able 
to adapt to the postnatal parameters assessed in this study.  
  
Despite having similar body weight at 6 months, PAI-1 and resistin levels were increased 
in MNR offspring. Both are produced primarily in adipose tissue in mice (16,17) and are 
associated with obesity and low-grade chronic inflammation (16,17,34). Individuals born 
SGA with the highest body mass index (BMI) have reduced insulin sensitivity (35). 
However, total fat pads are increased in female adult rats that experienced 50% nutrient 
restriction throughout gestation with similar adult body weights to controls (36). ELBW 
babies have also have similar BMI with increased body fat mass (3). Subsequently, 
increased markers for obesity and meta-inflammation may indicate reduced lean mass in 
male offspring in response to fetal undernutrition even with similar adult body weights. 
MNR offspring with glucose intolerance had higher serum resistin, and it cannot be 
excluded that increased fat mass may contribute to the development of glucose 
intolerance. 
 
Leptin was also increased in intolerant offspring. Serum leptin is correlated with body fat 
mass in humans (37) and mice(38), supporting the notion of differences in body 
composition. This marker could also indicate a decreased appetite in less tolerant MNR 
offspring. Alternatively, leptin resistance occurs in diet-induced obesity (39) and 
increased leptin in offspring with impaired glucose homeostasis may be a sign of leptin 
resistance. Leptin may also play a role in regulation of energy expenditure (39) and 
behavior changes, such as food preference and total activity. These behaviors are also 
altered in adulthood following IUGR or undernourishment during development (40,41). 
Increased serum leptin levels suggest that behaviors or body mass composition may be 
altered in susceptible MNR offspring and require further investigation.  
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Moderate nutrient restriction throughout gestation resulted in changes to the liver and 
adipose tissue including decreased fetal liver weight and increased adult insulin 
sensitivity in the liver. Serum markers for body mass composition and meta-inflammation 
were also increased. The liver is important in regulation of lipid and glucose metabolism 
and a key tissue in the development of type 2 diabetes. While it is possible that some 
adaptations occur in all offspring exposed to MNR, additional physiological and 
biochemical changes in the liver or other organs may be specific to those that develop 
glucose intolerance. This model provides an opportunity to investigate the tissue-specific 
molecular mechanism underlying changes between control and MNR as well as 
susceptible and resistance offspring. The variation in MNR offspring represents the 
diversity in human FGR populations and their susceptibilities towards type 2 diabetes 
(3,4).  
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Chapter 3 : High-Fat High-Sugar Diet Impairs Offspring 
Glucose Tolerance Independent of Poor Maternal Nutrition in 
Mice 
 
This chapter was submitted for consideration as a brief report in the Journal of 
Developmental Origins of Health and Disease (ID: DOHaD-11-18-BR-1072). 
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 Introduction 
Intrauterine growth restriction (IUGR) is a pregnancy condition where fetal growth is 
suboptimal, resulting in an infant born small for gestation age (<10th percentile). These 
infants have increased risk for perinatal morbidity and mortality (1), and as adults are 
more likely to develop obesity and type II diabetes (2,3). Common causes of IUGR 
include maternal malnutrition and placental insufficiency, both resulting in fetal nutrient 
restriction (4). It is thought that the fetus may adapt metabolically to enhance survival in 
a nutrient restrictive environment, but these adaptations may persist to adulthood where 
nutrients are abundant and increase the risk for metabolic diseases. This concept is 
termed the “thrifty hypothesis” (5). 
 
Modulation of the post-weaning diet may mediate these long-term effects. Studies have 
shown that ‘catch-up’ growth is associated maladaptive effects on glucose metabolism, 
and that dietary prevention of ‘catch-up’ growth is metabolically protective (6). A post-
weaning nutrient-rich diet provides a larger mismatch between fetal and post-natal 
environments that will increase ‘catch-up’ growth, worsening glucose intolerance and 
obesity (7). 
 
In humans and animals, a high caloric diet is associated with insulin resistance and type II 
diabetes (7,8). Different types of high caloric diets have been studied including high fat, 
fructose, sucrose, or to a lesser extent combination diets (9,10). While controversy exists 
on which type of diet is most harmful, excess calories seem to be important in metabolic 
disease promotion (8, 11). Regardless of the challenge, it is thought that fetal and adult 
diets can potentially interact and impact long term health. The data described in this 
report indicate a post-weaning high-fat high-sugar (HFHS) diet can disrupt adult glucose 
metabolism and overcome differences in offspring exposed to maternal undernutrition. 
 Methods 
 Animals 
All animal handling was completed within the University of Western Animal Ethics 
Guidelines (2017-033). Maternal nutrient restriction was used as described by Radford 
and Han, 2018 (12). Briefly, virgin 8-week-old female CD-1 mice were mated and 
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vaginal plugs indicated E0.5. At E6.5 pregnant mice were randomly assigned to ad 
libitum-fed controls or maternal nutrient restriction (MNR) (70% of ad libitum total 
calories)( #F0173, Bio-Serv, Flemington, NJ) until E18.5. Litters with 11-15 pups were 
cross-fostered to ad libitum-fed mothers. Fostered litters were culled or fostered to 13 
pups. At weaning, female offspring were euthanized and male offspring were randomly 
assigned to standard chow (Standard) or a high-fat high-sugar diet (HFHS) (Harlan 
TD.88137) (Table 3.2.1). The four groups studied were Control:Standard, 
Control:HFHS, MNR:Standard and MNR:HFHS (Figure 3.2.1). 
 
Weights were measured once a month from 1 to 6 months. Monthly non-fasted blood 
glucose was also measured (1030 h) using a tail vein puncture and the Freestyle Lite 
Glucometer (Abbott Laboratories, USA) (Control:Standard N= 25, MNR:Standard N=36, 
Control:HFHS N=33 and MNR HFHS N=52) (Figure 3.2.1). 
 
Table 3.2.1 Composition of Post-Weaning Diets. 
Diet Protein (% 
calories) 
Carbohydrates 
(% calories) 
Fat (% 
calories) 
Fat composition (% of 
diet) 
Sucrose 
(% by 
weight) 
Standard 
Chow 
(Teklad 
LM-485) 
25 17 58 0.8 saturated 
1.3 monounsaturated 
2.9 polyunsaturated 
- cholesterol 
30 
HFHS-diet 
(Harlan 
TD.88137) 
15 43 42 13 saturated 
6 monounsaturated 
1 polyunsaturated 
0.2 cholesterol 
12 
 
 Metabolic caging 
At 2 (N=4 per group) and 7-months (N=5 per group), metabolic analysis was assessed 
using the Comprehensive Lab Animal Monitoring System (CLAMS) with the Oxymax 
software (Columbus Instruments, Columbus, OH, USA) at the Robarts Research Institute 
(Figure 3.2.1). Mice were individually caged and acclimated for 16 hours. During the 
acclimation and measurement periods, cages were maintained at 24 ± 1 °C and mice 
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received free access to food and water. Measurements of respiratory exchange ratio 
(RER), food consumption, heat, and total activity were obtained every 10 minutes for 24h 
(12-h light/12-h dark), as previously described (13). Briefly, VO2 and VCO2 
measurements were normalized to body weight (mL/kg/h) and used to calculate RER 
(VCO2/VO2). The use of pure carbohydrates as a metabolic substrate would result in a 
RER of 1 and exclusive fat oxidation would be 0.7. Heat produced was also calculated 
with VO2 and RER [VO2 x (3.816 +1.232 x RER)]. To assess activity, infrared beam 
breaks were monitored. Total activity is the sum of ambulatory activity or consecutive 
breaks along the x and y axis, and stereotypy activity which is beam breaks that do not 
meet ambulatory threshold.  
 Glucose Tolerance and Pyruvate Challenge Tests 
For 6-month intraperitoneal glucose tolerance tests (IP-GTT), mice fasted for 4h (starting 
at 8 00 h) were injected intraperitoneally with glucose (2 g/kg). Blood glucose was 
measured at 0, 30, 60, 90 and 120 minutes via tail vein (Control:Standard N= 25, MNR: 
Standard N=36, Control:HFHS N=39, Control:HFHS N=63) (Figure 3.2.1). After one 
week of recovery, pyruvate challenge was completed with the same protocol as IP-GTT 
but pyruvate was injected at a dose of 2 g/kg (N=5 per group) (Figure 3.2.1).  
 Statistical Analysis 
All statistical and graphical analysis were completed in Graphpad Prism (version 5.2 and 
8). Mean body weights between groups were compared with a Mann-Whitney test. A 
two-way repeated measures ANOVA with a Bonferroni post-hoc was used to compare 
means from random blood glucose, glucose tolerance and pyruvate challenge tests. All 
data collected from metabolic caging was analyzed with a two-way ANOVA and a 
Bonferroni post-hoc test. 
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Figure 3.2.1 Litter and Sample Size Summary for MNR Offspring on a Post-
Weaning Standard Chow or HFHS diet. 
A cohort of male offspring on a post-weaning high-fat high-sugar (HFHS) from 19 MNR 
and 10 control litters was assessed for body weight, random blood glucose and glucose 
tolerance (A). Five offspring from separate litters were placed on a standard chow diet at 
weaning and compared to a littermate on a HFHS diet in metabolic cages (2 and 7 
months) and with a pyruvate challenge test (6 months) (B). A second cohort was 
produced with 5 control and 10 MNR litters to measure body weight, random blood 
glucose and glucose tolerance. Tissues from 1 and 6 months were also collected for 
studies not describes in this chapter. Note: the number of pups on the HFHS diet declined 
between 2 and 7 months due to mortality or ulcerative dermatitis.  
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 Results 
Birth and weaning weights of MNR offspring prior to exposure to a post-weaning HFHS 
diet were discussed in chapter 2. Weights of MNR and controls were similar from 1 to 6 
months on a HFHS diet. Weight from 1 to 6 months was significantly higher in HFHS-
fed offspring relative to those on standard chow (1 month Control:Standard and 
MNR:HFHS p = 0.03, and all other p < 0.0001) (Figure 3.3.1A).  
 
Random blood glucose measurements from 1 to 6 months did not differ significantly 
between maternal nutrition groups in HFHS-fed offspring. However, blood glucose levels 
were significantly increased from 1 to 5 months in HFHS-fed mice compared to standard 
chow-fed offspring (Figure 3.3.1B). These findings suggest that post-weaning diet, but 
not maternal nutrition, had an impact on growth and random blood glucose in the 
offspring. 
 
Glucose tolerance and hepatic glucose output were assessed with IP-GTT and pyruvate 
challenge tests, respectively. No differences in glucose tolerance were detected in 
between maternal nutrient groups within the same diet (Figure 3.3.1C). All HFHS-fed 
offspring had higher a blood glucose relative to those fed standard show in response to a 
glucose bolus at all time points (Figure 3.3.1C). AUCs for Control:HFHS (1001 ± 54.52) 
and MNR:HFHS (1126 ± 36.02) offspring during 6 month IP-GTT was higher than 
controls (538 ± 51.06) and MNR (692.2 ± 55.75) on standard chow fed offspring (p < 
0.0001) (Figure 3.3.1D). Hepatic glucose output during a pyruvate challenge test did not 
differ significantly between maternal nutrition status with similar post-weaning diets 
from 0-120 minutes (Figure 3.3.1E). Similar AUCs were also measured for control (811 
± 208.6) and MNR (762.4 ± 227.9) on HFHS (p = 0.88) (Figure 3.3.1F). These data 
suggest that a HFHS diet decreased glucose tolerance and caused a relative increase in 
hepatic glucose output in response to pyruvate (Figure 3.3.1); regardless of prenatal 
condition. 
 
Metabolic cages were used to compare post-weaning diets (HFHS and standard chow) or 
maternal nutrition (MNR and control). At 2 (Figure 3.2.2A) and 7 months (Figure 
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3.2.2B), a post-weaning HFHS diet significantly decreased RERs (2 month: light-cycle p 
= 0.01, dark-cycle p = 0.002; 7 month: light-cycle p = 0.0001, dark-cycle p = 0.0001), 
and increased heat produced (2 month: light-cycle p = 0.0001, dark-cycle p = 0.003; 7 
month: light-cycle p = 0.005). Maternal nutrient restriction significantly decreased 2-
month food intake during the day (p = 0.007) and activity at night (p = 0.01) (Figure 
3.2.2A). Seven-month-old MNR offspring also had reduced RER during light-cycle (p = 
0.04). There was no significant interaction between post-weaning diets and maternal 
nutrition in any parameters measured.   
 
Post hoc tests of metabolic parameters were used to compare MNR and control offspring 
on a HFHS diet. At 2 months, no differences in respiratory exchange ratios (RERs) or 
heat production were detected between Control:HFHS and MNR:HFHS(Figure 3.3.2A i 
and ii). Food consumption during the day was decreased in MNR:HFHS (6210 ± 572.5 
kCal) relative to Control:HFHS (9866 ± 545.1) (p = 0.004) (Figure 3.3.2A iii). No other 
parameters measured were significantly different between control and MNR on standard 
chow (Figure 3.3.2A) or on either diet at 7 months (Figure 3.3.2B). 
 
In addition to changes from maternal diet, effects of post-weaning diets in offspring with 
similar maternal nutrition was assessed. At 2 months, MNR offspring RERs were 
significantly lower on a HFHS (day= 0.8525 ± 0.01702, night= 0.8975 ± 0.019) relative 
standard chow (day= 0.94 ± 0.014 , night = 0.9900 ± 0.0041) during the day (p < 0.05) 
and night (p < 0.01) (Figure 3.3.2A i) and maintained to 7 months (daytime HFHS= 
0.8460 ± 0.018 and standard chow= 0.9500 ± 0.0084, nighttime HFHS= 0.8800 ± 0.018 
and standard chow= 0.9840 ± 0.014) (p < 0.01 and 0.001, respectively) (Figure 3.3.2B i). 
Decreased RERs in Control:HFHS relative to Control:Standard were only evident at 7 
months during both light and dark-cycles (p < 0.05 and 0.01 respectively). (Figure 3.3.2 
A i).  In 2-month-old control:HFHS diet had increased heat production (daytime= 0.5925 
± 0.026, nighttime = 0.6240 ± 0.0433) relative to controls on a standard chow diet during 
the light and dark-cycle (daytime = 0.4800 ± 0.01080, nighttime = 0.5120 ± 0.01655, p < 
0.01) (Figure 3.3.2A ii), which was maintain at 7 months during the light-cycle (p < 
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0.05). Heat produced was increased in 2-month old MNR:HFHS (0.5550 ± 0. 0.01848) 
compared to MNR:Standard (0.4700 ± 0.02449) during the day (p < 0.01), but was not 
maintained at night or 7 months. No other significant differences were detected between 
maternal nutrition on a similar post-weaning diet.  
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Figure 3.3.1 Weight and blood glucose regulation in MNR and control offspring. 
 
  
 
 
 
57 
A. Body weight was measured from 1 to 6 months. At one month, MNR were 
significantly smaller than controls on a standard chow diet (p = 0.006). No other 
differences were detected between maternal nutrition, but all offspring on a HFHS diet 
had significantly higher body weight relative to offspring fed standard chow (p < 0.05). 
B. MNR had similar random blood glucose to control offspring on similar post-natal 
diets. HFHS-fed offspring had significantly higher random blood glucose from 2 to 4 
months relative the same maternal diet group fed standard chow. MNR on a HFHS diet 
also had higher blood glucose at 5 months compared to MNR on standard chow. 
(Control:Standard N=25, MNR:Standard N=36, Control:HFHS N=33, MNR:HFHS N= 
52). C.  Glucose tolerance did not differ between control and MNR on similar diets and 
normalized blood glucose at all timepoints were higher on the HFHS diet-fed offspring 
compared to standard chow fed offspring from similar maternal diets. (Control:Standard 
N=25 , MNR:Standard N=36, Control:HFHS N=39, MNR:HFHS N= 63) D. Pyruvate 
challenge tests showed hepatic glucose output did not differ between control and MNR 
on similar diets, or between diets from the same maternal nutrition at all timepoints (N=5 
per group, 1 pup/litter in each group). Data are expressed as mean ± SEM. Man Whitney 
tests (A, Cii and Dii) or a two-way repeated measures ANOVA with a Bonferroni post-
hoc was used (B, Ci and Di). Different letters represent significant differences between 
maternal nutrition and asterisks represent significant differences between diets within the 
same maternal nutrient group.  
Sample numbers per month are as followed for A: 
Month Control:Standard MNR:Standard Control:HFHS MNR:HFHS 
1 37 52 52 82 
2 28 37 44 68 
3 28 37 43 73 
4 28 37 43 71 
5 28 37 42 66 
6 28 37 39 64 
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Figure 3.3.2 Metabolic caging data from 2 (A) and 7 (B) month-old offspring during 
the day (light cycle) and night (dark-cycle ). 
At two months, RER (A i) was significantly lower in MNR fed HFHS diets than MNR 
fed on standard chow at both light cycles (p = 0.002 and 0.03, respectively). Controls on 
a HFHS produced more heat than controls on standard chow during the day at 2 months 
(p = 0.01) (A ii). Control:HFHS consumed more food than MNR:HFHS (p = 0.004)(A 
iii) and total activity was decreased in MNR relative to controls on a HFHS diet (p = 
0.03) (A iv). In 7-month-old offspring RERs were reduced in MNR fed HFHS diets 
compared to MNR fed on standard chow at both light cycles (B i, p = 0.01 and 0.02, 
respectively). No other differences were detected at 7 months. Data are presented as the 
mean ± SEM). A two-way ANOVA was used to compare post-weaning and maternal diet 
or interactions between these parameters and the p-values are shown in the chart beside 
each graph. Bonferroni multiple comparisons were used for any changes detected and 
significant differences (p <0.05) are represented by an asterisk. 2 month N=4  and 7 
month N= 5 per group (1 mouse per litter). 
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 Discussion 
The concept of a ‘second hit’ such as a dietary challenge or sedentary life style is 
essential to the “Thrifty Phenotype Hypothesis”, where the fetus is primed to conserved 
nutrients but experiences a nutrient abundant post-natal environment. A HFHS diet was 
used in this study to mimic the western diet and investigate the role of a ‘second hit’ in 
the adult males. The MNR males were expected to have reduced glucose tolerance and 
insulin sensitivity compared to controls. However, MNR offspring showed no differences 
in glucose tolerance, hepatic glucose output, random and fasting blood glucose, RER, 
food consumption or activity compared to controls on a HFHS diet.  
 
Moderate nutrient restriction during pregnancy resulted in similar body weights in 
adulthood compared to controls on standard chow or HFD. Rat offspring from 50% 
maternal nutrient restriction late in gestation that were a fed standard chow (14) or a HFD 
(14,15) after weaning have also resulted in similar adult body weights to offspring from 
control pregnancies on the same postnatal diet. Increased growth of fat mass and 
phenotypic switching of pro-inflammatory macrophages (16) have been observed without 
changes in body weight and could impact the tissue function in MNR offspring. 
Conversely, mice with low maternal protein or calorie restriction throughout pregnancy 
became more obese than offspring from control pregnancies (17,18). This variation might 
be due to timing of catch-up growth, with catch-up growth prior to day 3 which was 
previously observed in this model (12) or after weaning (19) having a protective effect 
against diet-induced obesity. Additionally, although diet composition varied, daily calorie 
consumption was similar in all experimental groups, except at 2 months when 
MNR:HFHS ate less than Control:HFHS. If higher calories were consumed differences 
between MNR and control might have been observed.  
 
Maternal diet during pregnancy had no impact on non-fasting random blood glucose, 
glucose challenge or pyruvate challenge in our mouse offspring on a HFHS post-weaning 
diet. Rat offspring from low maternal protein throughout pregnancy and lactation or 
intrauterine artery ligation weaned into a HFD resulted in no significant differences in 
glucose tolerance (17,20), fasting and non-fasting blood glucose (20). Islet aging was 
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similar from a maternal HFD and maternal low protein, suggesting that both 
environmental exposures may converge on similar mechanisms (20). A similar 
mechanism underlying HFD exposure and reduced maternal nutrition could explain why 
there were no significant interactions in metabolic assessments and similar blood glucose 
regulation in MNR and control offspring fed a HFD. Conversely, evidence of maternal 
undernutrition with (15) and without (14) a high a caloric post- weaning diet causing 
decreased insulin sensitivity (14,15,21) or alterations in expression of hepatic genes 
important in gluconeogenesis (22) have been observed. The age of ‘catch-up’ growth and 
total calories consumed may have minimized differences between control and MNR 
offspring on HFHS. 
 
MNR on a HFHS diet showed decreased RERs at all ages and time points relative to 
MNR on standard chow, but this decrease was only significant in controls at 7 months. 
Pure carbohydrates as an energy source would result in a RER of 1 and oxidation of only 
fats would be 0.7. Reduced RERs imply decreased carbohydrate and increased use of fat 
as a metabolic substrate. Some studies indicate that nutrition during weaning or gestation 
impact RER only when stimulated with metabolic regulatory peptides such as 
adiponectin or leptin (21,23), which have not been assessed in this study. Stimulation by 
adiponectin or leptin may have been required to detect significant differences between 
maternal nutrition on the same diet or at other ages and time points. 
 
A calorie dense post-weaning diet did not significantly impact activity levels of offspring 
at 2 or 7-months old. Activity was also similar between control and MNR groups within 
the same post-weaning diet. Consistent with our results, no changes in energy 
expenditure from a calorie dense or standard chow diet were also observed in rat 
offspring from early gestation maternal nutrient restriction compared to controls (21). 
 
Both suboptimal nutrition during early development and a high caloric adult diet have 
been associated with increased appetite, changes in food preference and sedentary 
behavior (14,18,21,23,24). Conversely, restriction of nutrients during lactation by 
increasing litter size (23), adjusting maternal diet (18) or preconception maternal diet (24) 
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could have a greater impact on such behaviours compared to maternal nutrition alone. In 
fact 50% maternal nutrient restriction minimized sedentary behaviour induced by a HFD 
(14). In addition to minimal impact from maternal nutrition, diet did not lead to 
significant changes in food intake or activity. Rat offspring from maternal nutrient 
restriction resulted in increased caloric intake and reduced activity (21), suggesting that 
total calories rather than dietary composition could influence total activity. While the 
amount of food consumed did not differ in MNR offspring, preference for dietary intake 
of high fat or high sugar diets was not measured and cannot be eliminated in this study. 
Because maternal nutrient restriction was limited to pregnancy and offspring did not 
consume excess calories on the HFHS diet, changes to activity and food consumption 
were not observed in MNR offspring relative to controls. 
 
Moderate maternal nutrient restriction during gestation in mice did not result in 
differences in metabolic parameters measured in this study in response to a post-weaning 
isocaloric HFHS diet. The timing of the ‘second hit’ as well as the total calories 
consumed may have contributed to minimal interaction with maternal diet. However, 
MNR on standard chow started out with increased insulin sensitivity (12) and have 
similar abilities to regulate blood glucose on the high fat diet. A use of fat as a metabolic 
substrate was also more evident in MNR offspring at all time points, indicating that they 
may have been more impacted than controls. This study demonstrates differences due to 
maternal nutrition and the interaction with diet composition without excess calories and 
sedentary activity. Additionally, it underlines the importance of dietary composition in 
adult life.  
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Fetal Liver from Maternal Nutrient Restriction in Mice 
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 Introduction 
Intrauterine growth restriction (IUGR) is a pregnancy condition where fetal growth is 
suboptimal, resulting in an infant born with a birth weight <10th percentile (1). 
Individuals born from pregnancies complicated by IUGR are at increased risk for peri- 
and post-natal complications, and as adults are at increased risk for metabolic disorders 
(2,3). Adverse intrauterine conditions may lead to adaptations to enhance fetal survival 
but contribute to aberrant metabolism as adults (2). 
 
Hypoxia inducible factor (HIF) pathway is a cellular response to enhance survival in 
adverse conditions such as hypoxia and nutritional stress. Under normal physiological 
conditions, the a subunit (HIF-1a, HIF-2a, HIF-3a) is post-translationally hydroxylated 
and/or phosphorylated in the cytosol by regulators such as von Hippel–Lindau (VHL)/U3 
ligase complex, factor inhibitor of hypoxia (FIH) and glycogen synthase kinase 3b (GSK-
3b) (4–6). These post-translational modifications promote proteasomal degradation (4–6). 
During cellular stress, reduced hydroxylation and/or phosphorylation at stabilization sites 
inhibit recognition by the proteasome. Stabilization in the cytosol results in increased 
dimerization with the HIF-1b subunit. HIF dimers then translocate to the nucleus and 
transcriptionally regulate genes containing hypoxia responsive elements (HREs)(7). 
HRE-containing genes are involved in metabolism, cell cycle regulation and angiogenesis 
(5,7).  
 
Changes in HIF signalling in placentas from growth restricted pregnancies (8) or kidney 
and liver of maternal nutrient restricted IUGR animal models have been documented (8–
11). However, others fail to find differences in HIF signalling in these tissues (9,12). 
Previously we have shown that maternal nutrient restriction results in male offspring with 
reduced fetal and adult liver size and increased hepatic insulin sensitivity in adulthood 
(13). Here we aimed to investigate whether HIF signalling has a role in fetal liver 
adaptations after exposed to moderate calorie restriction in utero.  
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 Methods 
 Animals 
All animal procedures were approved by the Animal Use Subcommittee of the University 
Council on Animal Care at the University of Western Ontario and were described by 
Radford and Han, 2018(13). Briefly, mice were housed in 12-hour light and dark cycles. 
Virgin 8-week-old CD-1 female mice were bred, and the presence of a vaginal plug 
indicated E0.5. At E6.5, pregnant females received ad libitum standard chow (control, 
N=5) or maternal nutrient restriction (MNR, N=5) (70% total calories) (both groups 
receiving #F0173, Bio-Serv, Flemington, NJ). At E18.5 dams were euthanized with CO2 
narcosis and pups with cervical dislocation. Right liver lobes were removed from each 
pup, snap frozen in liquid nitrogen and stored at -80°C. Only male fetuses were identified 
with SRY PCR (forward primer - TGGACTGGTGACAARGCTA, reverse primer - 
TGGAAGTACAGGTGTGCACTCT) and used for further analysis. 
 RNA isolation 
RNA for sequencing was isolated from 10 control and 10 MNR livers (2 mice per litter). 
Additional RNA from 8 control and 8 MNR littermates (1 or 2 mice per litter) were used 
as a validation cohort for real time PCR.  Briefly, the frozen right liver lobe (30-50 mg 
for sequencing and 10-15 mg for real time PCR) was pulverised with a Bessman Tissue 
Pulveriser (Spectrum Laboratories, Rancho Dominguez, CA) then homogenized with a 
Brinkman homogenizer Polytron® 3000 for 50 seconds in 1mL or 500uL of ice cold 
trizol, respectively. The PureLink Mini RNA kit (Invitrogen, USA) with the on-column 
DNAseI treatment protocol was used to collect RNA from homogenate, as described by 
the manufacturer. 
 RNA sequencing 
RNA/library QC and RNA sequencing was run at McGill University and Genome 
Quebec Innovation Centre, Quebec, CA. Libraries were generated with the NEBNext® 
Ultra™ Directional RNA Library Prep Kit for Illumina® (E7420S, New England 
BioLabs, Massachusetts, United States). Quality of RNA was verified on the Agilent 
Bioanalyzer (RIN > 7). Single-read 50bp sequencing was obtained from a HiSeq 2500 
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with 17-31M reads per sample (average depth of 23M). Reads were aligned to the mm9 
transcriptome (14) with Bowtie2 (15) (90% alignment rate). 
 Real time PCR 
 Complementary DNA was generated with the SuperScript™ IV First-Strand Synthesis 
System (Invitrogen, USA). Taqman assays that covered multiple exons were purchased 
for select target genes including: Cyclin G2 (Ccng2) (4448892, Mm00432394_m1), B-
cell Translocator Gene 2 (Btg2) (4453320, Mm00476162_m1), Lysine Demethylase 3A 
(Kdm3a) (4448892, Mm01182127_m1), FK506 Binding Protein (Fkbp5) (4448892, 
Mm00487406_m1), 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 (Pfkbp3) 
(4448892, Mm00504650_m1), Hypoxia Inducible Factor 3a (Hif-3a) 
(Mm00469375_m1), von Hippel–Lindau (Vhl) (Mm00494137_m1), Hypoxia Inducible 
Factor 1a (Hif-1a) (Mm00468869_m1), and Hypoxia Inducible Factor 2a (Hif-2a) 
(Mm01236112_m1); and endogenous controls Glyceraldehyde-3-Phosphate 
Dehydrogenase (Gapdh) (4331182, Mm99999915_g1) and beta actin (4331182, 
Mm01205647_g1) (Invitrogen, USA). Reactions were run with TaqMan™ Fast 
Advanced Master Mix (Invitrogen, USA) on the ViiA™ 7 (Applied Biosystems, USA) 
according to the manufacturers protocol. Fold change was calculated using the delta delta 
CT method (ddCT). 
 Protein Isolations 
Ten-Fifteen mg of tissue was homogenized with 1mL of ice cold 1x Cell Lysis buffer 
(9803S) from Cell Signaling (Danvers, MA, USA) with protease inhibitor cocktail 1, 2, 
and 3 (P1860, P5726, and P0044, Sigma-Aldrich, St. Louis, MO, USA) for 40 seconds 
with a Brinkman homogenizer Polytron® 3000. Lysates were sonicated (F550 Sonic 
Dismemberator, Fisher Scientific, Markham, ON Canada) and then shaken at 4°C for 2 
hours. Cellular debris was removed from lysates by spinning at 12,000 x g for 10 minutes 
and the supernatant was collected for analysis. Protein concentrations were calculated 
with the Bio-Rad Protein Assay (Cat #500-0006, Bio-Rad Laboratories Inc., Des Plaines, 
IL) according to the manufacturer’s protocol. 
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 Western Blotting 
Fifty µg of protein for HIF-2a blots and 25µg for all other blots were loaded and run on 
an 8% polyacrylamide gel. Protein was transferred to a PVDF membrane with the 
Transblot TurboTM (Bio-rad Laboratories Inc., USA). Membranes were dipped in methanol 
and then blocked for an hour at room temperature in 5% milk in TBST. After rinsing 3 
times (5 minutes each) in TBST, primary antibodies were incubated in 5% BSA in TBST 
overnight (Table 4.2.1). Blots were rinsed 3 times (5 minutes each) and incubated with 
secondary antibodies in 5% milk in TBST for 1 hour at room temperature (Table 4.2.1). 
Blots were images with the ClarityTM Western ECL Substrate (1705061, Bio-Rad 
Laboratories Inc., Des Plaines, IL) and band intensities were quantified using Imagelab 
software® version 5.1 BETA (Bio-Rad Laboratories Inc., Des Plaines, IL). Kdm3a was 
not assessed via western blot because we were not able to find an effective antibody for 
the mouse fetal liver samples. All sample lysates were run on three western blots to 
generate technical replicates for statistical comparisons. Only one representative blot is 
shown. 
 Statistical analysis 
Samples that contributed more variation than expected to the each group were removed 
as outliers as described by Gierliński et al. with the median plus 2 times the interquartile 
range as the threshold (16). Differential expression was detected with a false discovery 
rate (FDR) < 0.1 and detection in 2 or more tools (EdgeR(17), DESeq2(18) and 
ALDex2(19)) using the default settings in R (version 3.4.3). Optimal number of clusters 
were generated with the gap statistic with the Cluster library (version 2.0.6) and PCA 
plots were plotted with ggplot2 (version 2.2.1) and ggrepel (version 0.8.0) in the R 
console (version 3.3.2 and 3.4.3). Gene ontology (GO) pathway enrichment was done on 
the Gene Ontology Tool (Panther)(20,21); and KEGG and NCI pathway enrichments 
were run on enrichR (22,23). For quantitative PCR (qPCR) and western blots unpaired t-
tests were used to compare delta CT values or band intensities respectively on Graphpad 
Prism (version 5.2). 
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Table 4.2.1 Antibodies used for western blotting 
Target Company Cat. No Dilution 
HIF-2a Santa Cruz Biotechnology Inc. sc-13596 1:250 
HIF-3a Santa Cruz Biotechnology Inc. sc-390933 1:200 
FKBP5 Santa Cruz Biotechnology Inc. sc-271547 1:200 
PFKFB3 Cell Signaling 13123S 1:1000 
Mouse IGG Bio-Rad Laboratories Inc. 170-6515 1: 10 000 
 
 Results 
RNA sequencing data was assessed for sample outliers and gene distributions among 
remaining samples (16). One control and one MNR sample contributed more variance to 
their respective maternal nutrient groups than other samples within the group and were 
removed from further analysis (Figure 4.3.1). With remaining samples, two distributions 
of genes were formed along PC1 (Figure 4.3.2). The second distribution contained genes 
enriched in GO pathways in neural and epithelial cell development (Supplementary 
Table 4.3.1), since hepatocyte and hematopoietic populations are of primary interest in 
this study this second distribution of genes was removed from the analysis. 
 
Overall gene expression was explored with PCA (principal component analysis) plots and 
cluster analysis. The optimal number of clusters with the gap statistic of the centered-log 
ratio and regularized-log ratio transformed data was 1. However, k-means clusters with 
k=2 resulted in clusters separating based on counts per sample (Figure 4.3.2A and 
Supplementary Table 4.3.2). The PCA plot of the top 500 variable genes from the 
centred-log ratio (Figure 4.3.3A) did not result in separation of samples based on 
maternal nutrition. Regularized-log ratio transformed data PCA of the top 500 variable 
genes indicates moderate separation of maternal nutrition along PC1. Although PC1 only 
explains 8% of the total variance in the samples (Figure 4.3.3B). These data suggest that 
overall gene expression was similar between control and MNR fetal livers. 
 
Despite similar overall expression, 49 protein-coding genes were differentially expressed 
in MNR fetal livers relative to controls using a false discovery rate (FDR) cut-off of < 0.1 
and consistency of two or more tools (Supplementary Table 4.3.3). GO enrichment 
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indicated negative regulation of transcription from RNA polymerase II promoter in 
response to hypoxia as the top pathway when ranked according to fold enrichment 
(Cited2 and Vhl) (Figure 4.3.4A). Hypoxia signalling was also the top pathway 
enrichment according to combined scores with KEGG (Figure 4.3.4B) and NCI (Figure 
4.3.4C). Additional genes included in these enrichments are Pfkfb3 and Hif-3a. 
Investigation into gene functions of differentially expressed genes indicate further 
involvement in cellular response to hypoxia (Figure 4.3.5 and Supplementary Table 
4.3.4). 
 
Genes involved in hypoxic regulation of metabolism, cell cycle regulation and chronic 
hypoxia were selected to be validated by qPCR in a separate validation cohort (Figure 
4.3.6). Pfkfb3 transcript was increased 1.8-fold (p = 0.002) in MNR relative to controls, 
similar to the fold change in the RNAseq data of 1.5 (FDR = 1.2x10-6). Fkbp5 and 
Kdm3a transcripts were also confirmed to be increased by 1.3 and 1.5-fold (p = 0.03 and 
0.02) and similar to sequencing fold changes of 1.6 and 1.2, respectively (FDR = 0.006 
and 0.04). Lastly, Hif-3a was significantly higher by 1.4-fold in the MNR livers in the 
validation cohort (p = 0.01), similar to the 1.3-fold increased initial MNR cohort (FDR = 
0.009). Although not significant, Ccng2, which was 1.5-fold higher in the RNAseq data 
(FDR = 0.0001), was relatively higher in the MNR fetal livers by 1.4-fold (p = 0.05). 
Btg2 and Vhl were not significantly different in the validation cohort (p = 0.1 and 0.7). 
Hif-1a and Hif-2a transcripts were not significantly different in the initial MNR cohort, 
but Hif-1a was 1.3-fold decreased in the validation MNR group used for qPCR relative 
to controls (p = 0.01). 
 
Protein levels for genes differentially expressed in the validation cohort, as well as HIF-
2a, were determined by western blots (Figure 4.3.7). HIF-1a was not detected in the 
fetal liver (Supplementary Figure S4.3.1) but HIF-2a was increased 2.2-fold in MNR 
fetuses (p = 0.002). HIF-3a was also increased by 1.3-fold (p = 0.03) in MNR relative to 
controls (Figure 4.3.7A and B). FKBP5 and PFKFB3 protein levels were not 
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significantly different between maternal nutrient groups (1.6 1.3-fold change, p = 0.09 
and 0.5, respectively) (Figure 4.3.7C and D). 
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Figure 4.3.1 Biplots of E18.5 liver RNA sequencing data transformed with the 
centered-log ratio for controls (A) and MNR (B). 
Group outliers are indicated by the red box. N=10 for both groups.  
A                                                    B
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Figure 4.3.2 Distribution of genes in the center-log ratio transformed data. 
Two overlapping distributions of genes contributing to PC1 are visible on the biplot, 
which are not separating based on maternal nutrition or litters (Group-Litter, Group= 
Control (C) or MNR (M) and Litters= A to J) (A). Two clusters are formed (k-means) 
(cluster 1 = grey, cluster 2 = black). Histograms of all rotation values (B i) with a black 
box indicating rotation values between -0.004 and 0.004. Distribution 1(left) and 2(right) 
are separated by the red line (B ii) in a histogram only showing rotation values between -
0.004 and 0.004. Control N=9 and MNR N=9, 1-2 pups/litter. 
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Figure 4.3.3 PCA of the top 500 variable genes. 
Data was transformed with the centered-log ratio (A) and regularized log ratio (B). 
Control N=9 and MNR N=9, 1-2 pups/litter. 
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For B and C, significant pathways are in red and the bar size represents the combined 
scores.   
A
B.                                                             C.
Figure 4.3.4 Top 10 gene ontologies (A), KEGG (B), and NCI:Nature (C) gene 
pathway enrichments with protein-coding genes differentially expressed between 
control and MNR. 
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Figure 4.3.5 Genes differentially expressed in the RNAseq data (FDR <0.1 in 2 or 
more differential expression tools) in hypoxic inducible factor signalling. 
Upregulated, down-regulated or no change. Boxes indicate genes selected for qPCR in a 
validation cohort, along with HIF-1a and HIF-2a. 
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Figure 4.3.6. Relative fold change for genes involved in HIF signalling validated in 
an additional cohort with qPCR. 
Data are plotted as mean ± SEM and asterisks represent p < 0.05 with an unpaired t-test. 
Control N=8 and MNR N=8, 1 or 2 pups/litter. 
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Figure 4.3.7 Western blots of proteins confirmed to be differentially expressed in the 
validation cohort. 
HIF-2a (A) and HIF-3a (B) were significantly increased in MNR offspring by 2.2 and 
1.3-fold (p = 0.002 and 0.03, respectively). FKBP5 (C) and PFKFB3 (D) were not 
significantly different in MNR relative to controls (p = 0.09 and 0.5, respectively). All 
blots were run in triplicates and representative blots are shown. Data are plotted as mean 
± SEM and asterisks represent p < 0.05 with an unpaired t-test. Control N=6 and MNR 
N=7, 1 or 2 pups/litter.  
 
 
 
82 
 
 Discussion 
HIF-2a protein was increased in MNR offspring, but HIF-1a was not detected. Normal 
development in cells, such as endothelial cells, involve a switch from HIF-1a to HIF-2a 
as the primary HRE transcriptional regulator, similar to the transition observed with 
chronic hypoxia in cancer cells (24,25). During the liver bud maturation the HIF-1a 
transcript decline is associated with a shift in hepatoblast differentiation from biliary cells 
to hepatocytes (26). Although not known, it is conceivable that the developing liver shifts 
from HIF-1a to HIF-2a as well. In other tissues this switch is thought to occur in part 
because oxygen tension increases as organ perfusion during development becomes more 
efficient. FIH and PHDs less efficiently hydroxylate HIF-2a allowing it to stabilize and 
accumulate longer than HIF-1a (27,28). Additionally, differential expression of miRNAs 
can lead to decreased Hif-1a mRNA stability but not Hif-2a (29). HIF-1a and HIF-2a 
have both redundant and non-redundant gene targets that depend on cellular context and 
cell type (24,30). The presence of HIF-2a but not HIF-1a is likely due to the late-
gestational sampling in this study and duration of hypoxia signalling. 
 
Hif-3a mRNA and protein were higher in MNR compared to controls. Hif-3a mRNA is 
induced by HIF-1a during chronic hypoxia and transcriptionally down-regulates Hif-1a 
as a negative feedback mechanism (31,32). In mice Hif-3a has three isoforms, a full-
length transcript and two variants, IPAS and NPAS. All three isoforms can inhibit the 
transcriptional activity of HIFs by binding with HIF-1b or HIF-1/2a, preventing 
dimerization and nuclear translocation (33). Some HIF-3a splice variants can also 
weakly induce canonical HIF-1a target genes (34). Consequently, increased HIF-3a 
protein could contribute to moderate differences between control and MNR HIF-induced 
transcription.  
 
Fkbp5 was also increased at the transcript level and, although not significant, relatively 
increased at the protein level. FK506 Binding Protein (FKBP5) functions as co-chaperon 
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to HSP90 and as a scaffold protein. Subsequently, FKBP5 has diverse functions including 
reducing the affinity of glucocorticoid to the glucocorticoid receptor and promotion of 
adipocyte differentiation (35,36). As a chaperone FKBP5 also promotes the folding of 
PHLPP (a key phosphatase for AKT) resulting in reduced AKT phosphorylation (37). In 
adipose tissue chronic hypoxia results in increased FKBP5 (36) and in hepatocellular 
carcinoma cell lines sorafenib treatment resulted in HIF-2a-dependant induction of 
Fkbp5 transcription (38). FKBP5 has also been shown to regulate CDK5 interaction with 
DNMT1 and reduce DNA methylation activity (39). Most studies have been in neural 
cells or adipocytes, but this study suggests that FKBP5 may play a role cellular stress in 
the developing liver. An increase in FKBP5 could be induced by HIF-2a in MNR 
offspring, influencing metabolism, cell growth and/or DNA methylation. 
 
Changes to hypoxia signalling in the liver could be indirect through placental adaptations. 
Decreased placental size could reduce oxygen and nutrient delivery, although the 
junctional zone is more impacted than the labyrinth zone (40). In guinea pigs, MNR 
results in increased hypoxyprobe-1 staining in both male and female liver and kidneys 
(10). However, no differences were detected in the placentas (10). Alternatively, MNR 
could increase HIF signalling in the developing liver through nutritional signalling and/or 
changes to fetal circulation. Further studies into the mechanism of HIF signalling need to 
be elucidated. However, increased HIF-induced transcripts support the concept that MNR 
results in increased hypoxia signalling in the fetal liver.  
 
Maternal nutrient restriction resulted in fetal expression changes in hypoxia-inducible 
signalling pathways of E18.5 liver. Although expression changes were detected, the 
protein levels of genes induced by HIF transcription factors were not significantly 
different. Since tissue hypoxia declines during development (24, 26) it is possible that 
downstream changes were more evident earlier in liver development. Still, due to their 
importance in regulating multipotency, cell differentiation, and proliferation, HIF-
induced transcription could result in differences in liver maturity and cell populations. 
Additionally, differential expression of epigenetic regulators such as Kdm3a and Fkbp5 
may prime HRE-containing genes to respond differentially to aging or nutritional 
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abundance. Evidence of aberrant hypoxia signalling was evident in growth restricted 
mice, but the impact was moderate which may relate to the duration of nutrient restriction 
and the timing of analysis. Differentially expressed transcripts support the concept that 
hypoxia signaling may play a role in growth restriction in response to fetal 
undernutrition.  
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Chapter 5 : Similar Gene Expression in Adult Liver, Adipose 
Tissue and Skeletal Muscle of Maternal Nutrient Restricted 
Offspring Susceptible or Resistant to Changes in Glucose 
Metabolism 
 
The following chapter contains a manuscript prepared for submission in PLOSone 
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 Introduction  
Intrauterine Growth Restriction (IUGR) is a pregnancy condition where fetal growth is 
suboptimal, resulting in an infant born with a birthweight <10th percentile. The most 
common cause in developed countries is poor placental development (placental 
insufficiency) and in under-developed countries is maternal malnutrition (1). In both 
placental insufficiency and maternal malnutrition, the fetus is undernourished during 
development and the gestation at which it is impacted depends on the timing and type of 
pathology. In the short term, infants from IUGR pregnancies have higher morbidity and 
mortality rates in the perinatal and neonatal periods (2). As adults, offspring from IUGR 
pregnancies are also at increased risk for adult diseases such as cardiovascular disease, 
glucose intolerance and type 2 diabetes (3). 
 
Initial studies demonstrating convincing evidence between pathologically small birth 
weights and long-term metabolic outcomes were in cohorts of the Dutch famine. Ravelli 
et al (1998), described an increased occurrence of glucose intolerance in these adults 
whose mothers experienced the Dutch famine during pregnancy (4). Further studies of 
this population, other IUGR populations and animal models have also demonstrated an 
influence of fetal environment on adult health (5–8). Such studies have led to the concept 
of ‘Developmental Origins of Health and Disease’ (DOHaD). In this concept, adversity 
during fetal and early life can lead to adaptations that may temporarily improve survival. 
However, these adaptations may not be beneficial to those individuals as an adult (9). 
One mechanism of fetal adaptation is through epigenetic changes such as DNA 
methylation, histone modifications, and differential miRNA expression, which result in 
altered gene expression that influence organ development or cell function in 
metabolically important tissues. The epigenetic marks can persist until later in life 
(adulthood) and may lead to altered gene expression and pathology. 
 
The adaptations can be tissue-specific making animal models useful when studying long-
term metabolic impacts of fetal undernutrition. Previous work in our laboratory has 
established a mouse model of IUGR using maternal nutrient restriction (MNR) (10). 
MNR male offspring from this model experienced growth restriction and had smaller 
liver-to-body weight ratios (10). At 6 months, 19% of the MNR offspring were glucose 
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intolerant and the remaining were not susceptible to glucose tolerance changes (10). 
Despite the variation in glucose tolerance, most MNR had increased hepatic insulin 
sensitivity (10). The aim of this study was to identify tissue-specific expression changes 
that occur in response to fetal undernutrition in all MNR and/or in susceptible MNR 
offspring. Liver, adipose tissue and skeletal muscle were the tissues of focus because 
insulin sensitivity in these tissues precedes the development of type 2 diabetes (11). 
Although at increased risk, not all individuals born from IUGR pregnancies will develop 
metabolic disorders. Understanding the expression changes associated with susceptible 
and resistant growth restricted populations to changes in glucose tolerance could help 
identify IUGR populations in humans that will develop an altered glucose metabolism as 
adults. 
 Methods 
 Animals 
All animal care and procedures were approved by the Council on Animal Care at the 
University of Western Ontario and as previously described (10). Briefly, pregnant CD-1 
mice received ad libitum food or maternal nutrient restriction (MNR) (70% of ad libitum) 
from E6.5 until birth. Only litters with 11-15 pups were studied and male to female ratios 
did not vary between control and MNR litters (10). All pups were cross-fostered to an ad 
libitum-fed mother at birth with litters culled or fostered to 13 pups per litter. Male 
offspring were weaned onto a standard chow diet (Teklad LM-485 Mouse/Rat 
Sterilizable Diet, Harlan Laboratories, USA). At 6 months, offspring were euthanized by 
CO2 necrosis (8 30 to 10 00 h) and right medial liver lobes, perigonadal fat pads, and 
quadriceps femoris were snap frozen in liquid nitrogen. Frozen tissues were stored at -
80°C until further analysis. 
 RNA isolation 
Fifty mg of liver (control N=8, intolerant MNR N=7, tolerant MNR N=8) and skeletal 
muscle (control N=8, intolerant MNR N=9, tolerant MNR N=8) and 100 mg of adipose 
tissue (control N=8, intolerant MNR N=9, tolerant MNR N=8) was pulverized and then 
homogenized for 50 seconds in 1 mL of ice cold TRIzol (InvitrogenTM, Carlsbad, CA, 
USA). RNA was extracted from homogenate with RNA PureLinkTM mini kit 
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(InvitrogenTM, USA) according to the manufacturer’s TRIzol and on-column DNAseI 
treatment protocol. RNA quality was verified (RIN ³ 7) with an Agilent Bioanalyzer 
2100 at McGill University and Génome Québec Innovation Centre (Montreal, QC, 
Canada) and the National Research Council Canada (NRC) (Saskatoon, SK, Canada). 
 RNA sequencing 
Library preparation and quality control for the liver and skeletal muscle were done at the 
McGill University and Génome Québec Innovation Centre (Montreal, QC, Canada) with 
the Illumina TruSeqTM mRNA Stranded library kit (Illumina). Single-reads sequencing 
was run on a HiSeq 2500 and the average read depth was 13 million per sample. Adipose 
RNA libraries and QC were prepared by the National Research Council Canada (NRC) 
(Saskatoon, SK, Canada) using the NEBNext® Ultra™ II Directional RNA Library Prep 
Kit for Illumina®. An average of 8 million paired reads per sample were obtained. Reads 
from all tissues were aligned to the mm9 transcriptome with Bowtie2 (12). Quality 
control of reads and removal of adapters or primer sequences were done with the Trim 
Galore (version 0.4.4) library. 
  Differential Gene Expression and Pathway Enrichment  
Genes with no counts per samples were removed from count tables. Outlier detection, 
PCA plots and differential expression were done in the R console (version 3.3.2) (13) 
with Z Compositions (version 1.1.1) (14), CoDaSeq (version 0.99.1) (15,16) and ggplots2 
(version 2.2.1) (17) libraries. Sample outliers in glucose tolerance groups with variation 
greater than the median plus 2 times the interquartile ratio were removed, as described by 
Gierliński et al. (Supplementary Figure S5.2.1-5.2.3) (18). The impaired fasting blood 
glucose (IFBG) group, which exhibited higher blood glucose than any controls 
(Supplementary figure S5.2.4), had a small sample size (N=4) and were not assessed for 
outliers. EdgeR (19), DESeq2 (20), and Aldex2 (21) tools were used in differential 
expression analysis and protein-coding genes were considered differentially expressed if 
there was consistency in two or more tools (FDR < 0.1, > 2-fold change). Gene ontology 
enrichment was done on the panther online tool (22,23), and NCI:Nature and KEGG 
enrichment was done on the EnrichR online tool (24,25). 
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 Results 
Gene expression of control and MNR offspring, as well as tolerant and intolerant MNR, 
were assessed in the right medial liver lobe, quadriceps femoris muscle and perigonadal 
adipose tissue at 6 months. PCA plots of expression data within each tissue suggest that 
samples do not cluster based on maternal nutrition or glucose tolerance in all three tissues 
(Figure 5.3.1 and Supplementary Figure S5.3.1). Sample-to-sample plots also 
demonstrate that samples do not separate based on maternal nutrition or glucose tolerance 
(Figure 5.3.2). 
 
Although tissues showed similar overall gene expression, we examined pathway 
enrichment of genes differentially expressed between maternal nutrition and glucose 
tolerance groups (Table 5.3.1-5.3.3 and Supplementary Table 5.3.1). In the liver, 6 
genes were differentially expressed in MNR offspring relative to controls (Table 5.3.1 
and Supplementary Table 5.3.1). These genes include three heat shock protein 
chaperons (Hspab1, Hspa11) as well as FGF11 which are involved in MAPK signalling. 
Both heat shock proteins and Alas1 are also involved in the immune response to Epstein-
Barr virus infections. Twenty four genes are differentially expressed in intolerant MNR 
relative to controls (Table 5.3.1 and Supplementary Table 5.3.1) including three heat 
shock proteins (Hspa1a, Hspa11, and Hsp1b) that are involved in cellular response to 
heat, unfolded proteins, immune response, MAPK pathway (Ntrk2, Fgf11), and longevity 
and estrogen signalling pathways (Adcy1). Pathway enrichment also shows differences in 
intolerant MNR in tyrosine receptor signalling (Dnaic1, Pdk4, Gdf15, Hspb1, and Ntrk2) 
and p53 effectors (Hspa1a, Fdf15). Although not indicated by pathways enrichment, 
differentially expressed genes associated with obesity, lipid metabolism and adipogenesis 
were increased (Vldlr, Adcy1, Ntrk2) or decreased (Cyp26b1) in intolerant MNR relative 
to controls (26,27). Despite differential expression of 7 genes in MNR with impaired 
fasting blood glucose, no pathways were enriched (Table 5.3.1 and Supplementary 
Table 5.3.1). Similar to intolerant MNR, genes involved in lipid and cholesterol 
metabolism were decreased (Cyp26b1, Mfsd2a, Cyp2b10)(28) in the impaired fasting 
blood glucose cohort. Only metallothionein 1 was differentially expressed between 
tolerant and intolerant MNR, and subsequently no pathways were enriched. 
 
 
 
 
95 
Minimal transcriptome changes were evident in 6-month quadriceps femoris muscle 
(Table 5.3.2 and Supplementary Table 5.3.1). Furthermore, no genes were 
differentially expressed between all MNR and controls. Only 3 genes in intolerant MNR 
and 4 genes in MNR exhibiting a higher fasting blood glucose and were differentially 
expressed compared to controls. Potassium voltage-gated channel, shaker-related, 
subfamily, member 6 (Kcna6) was differentially expressed between tolerant and 
intolerant MNR. No pathway enrichment was found in differentially expressed genes 
(Table 5.3.2). 
 
In the adipose tissue differential gene expression analysis also revealed minimal 
differences between control and MNR offspring (Table 5.3.3 and Supplementary Table 
5.3.1). Napsin A aspartic peptidase (Napsa) was differentially expressed between all 
MNR and controls. In the intolerant and impaired fasting blood glucose groups, 6 and 2 
were differentially expressed between relative to controls, respectively. No genes were 
differentially expressed between tolerant and intolerant MNR. None of the genes 
differentially expressed in adipose tissue between maternal nutrition or glucose tolerance 
groups were significantly enriched in pathways (Table 5.3.3).  
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Figure 5.3.1 PCA plots of liver (A), skeletal muscle (B), and adipose tissue (C) 
demonstrate similar overall expression between control (grey) and MNR (black), 
and between glucose tolerance groups (symbols). 
Plotted data was transformed with the centered log ratio and filtered for the top 500 
variable genes. 
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Figure 5.3.2 Sample-to-sample plots of RNAseq centered-log ratio transformed data 
from the liver (A), skeletal muscle (B), and adipose tissue (C). 
Samples did not cluster based on maternal nutrition (Y-axis) or glucose tolerance (X-
axis). 
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Table 5.3.1 Pathway enrichment of differentially expressed genes (FDR <0.1 in 2 > 
tools) in the liver of 6-month offspring. 
Reference Group Comparison Group # Genes GO Enrichment KEGG Enrichment 
Control 
All MNR 6 NA 
MAPK signalling pathway 
(20.24) (Hspb1, Hspa1l, 
Fgf11)  
 
Epstein-Barr virus infection 
(12.53) (Hspb1, Hspa1l, 
Alas1) 
 
Intolerant 
MNR 24 
Protein refolding 
(4.49E-03), Chaperone 
cofactor-dependent 
protein refolding 
(1.04E-02), Cellular 
response to unfolded 
protein (4.14E-02), 
Cellular response to 
heat (4.07E-02) 
(Hspa1a, Hspa1l, 
Hspa1b) 
 
Transmembrane 
receptor protein 
tyrosine kinase 
signalling pathway 
(2.56E-02) (Dnaic1, 
Pdk4, Gdf15, Hspb1, 
Ntrk2) 
MAPK signalling pathway 
(29.20) (Hspa1a, Hspa1l, 
Hspa1b, Ntrk2, Fgf11, 
Hspb1) 
 
Longevity regulating pathway 
(27.42), Estrogen signalling 
pathway (22.60) (Hspa1a, 
Hspa1l, Hspa1b, Adcy1) 
 
Antigen processing and 
presentation (14.94), 
Toxoplasmosis (13.94), 
Measles (12.40), Spliceosome 
(12.23), Influenza A (11.56), 
Legionellosis (18.25) 
(Hspa1a, Hspa1l, Hspa1b) 
MNR with 
Higher 
Fasting 
Blood 
Glucose 
7 NA NA 
Tolerant MNR Intolerant MNR 1 NA NA 
 Note: Combined scores (KEGG and NCI:Nature) or FDR (GO) per pathway are 
indicated in brackets, followed by the genes included in the pathway. 
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Table 5.3.2 Pathway enrichment of differentially expressed genes (FDR < 0.1 in 2 > 
tools) in skeletal muscle of 6-month-old offspring. 
Reference Group Comparison Group # Genes GO Enrichment KEGG Enrichment 
Control 
All MNR 0 NA NA 
Intolerant 
MNR 3 NA NA 
MNR with 
Higher 
Fasting Blood 
Glucose 
4 NA NA 
Tolerant MNR Intolerant MNR 1 NA NA 
Note: Combined scores (KEGG and NCI:Nature) or FDR (GO) per pathway are indicated 
in brackets, followed by the genes included in the pathway. 
 
 
 
Table 5.3.3 Pathway enrichment of differentially expressed genes (FDR < 0.1 in 2 > 
tools) in adipose tissue of 6-month-old offspring. 
Reference Group Comparison Group # Genes GO Enrichment KEGG Enrichment 
Control 
All MNR 1 NA NA 
Intolerant 
MNR 6 NA NA 
MNR with 
Higher 
Fasting Blood 
Glucose 
3 NA NA 
Tolerant MNR Intolerant MNR 0 NA NA 
Note: Combined scores (KEGG and NCI:Nature) or FDR (GO) per pathway are indicated 
in brackets, followed by the genes included in the pathway. 
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 Discussion 
In our mouse model of fetal growth restriction, the overall gene expression in 6-month-
old liver, adipose and skeletal muscle was similar for offspring of maternal nutrition 
restriction and control pregnancies, and glucose tolerant and intolerant groups. Increased 
p-AKT to AKT ratios in response to insulin occurred in the liver of most MNR, but a 
cohort of MNR offspring were susceptible to impaired glucose tolerance with a higher 
under the curve (AUCs) during the glucose tolerance test than any controls (10). 
However, these changes are moderate and most evident after an insulin or glucose bolus 
(10). Subsequently, the gene expression changes may be detectable after during 
metabolic stress. Alternatively, impacts on transcription could be proportional to the 
extent of maternal nutrient restriction. For example, transcription of genes involved in 
regulation of epigenetics, circadian rhythms and lipid or glucose metabolism are altered 
at weaning in offspring from 50% MNR throughout or late gestation to weaning (29,30). 
These IUGR models are also in rats which have lower metabolic rates than mice (31). In 
humans, basal metabolic rate is negatively correlated to insulin resistance (32) and could 
suggest rats are more sensitive to disruptions in glucose homeostasis. Gene expression 
changes in tissues could also decrease with age. Even with 50% MNR in rats, a low 
number of genes and magnitude of effect are present in offspring at postnatal day 450 
(30). It is also possible that gene expression changes occurred in tissues not assayed in 
this study. One study showed that transcriptional responses to maternal protein restriction 
was specific to each organ in the fetus (33). 
 
Although transcription changes were limited in MNR offspring, liver had the most 
differentially expressed genes. Two heat shock proteins (HSPs) were decreased in all 
MNR and three in intolerant MNR. Small (Hspb2) and large (Hspa1a, Hsp1l, and 
Hspa1b) HSPs act as chaperons and are induced during cellular stress. Reduced HSP 
expression could indicate decreased cellular stress or a reduced response to similar stress 
in MNR compared to controls. For example, increased ER stress occurs in rat offspring 
from maternal protein restriction (34). Apart from the unfolded protein response, HSPs 
mediate protein-protein interactions and function in prevention of apoptosis in mitophagy 
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(35). Increased intracellular Hspa1a is associated with increased insulin sensitivity in 
skeletal muscle but extracellular Hspa1a may decrease insulin sensitivity (36–38). 
Depending on the cellular location, reduced Hspa1a expression in intolerant MNR could 
have anti-inflammatory or proinflammatory effects, reducing or promoting insulin 
sensitivity, respectively (36-38). HSPs also regulate cellular localization of transcription 
factors such as the androgen receptor (39) and this pathway was not enriched in the 
differentially expressed genes. Heat shock transcription factors (HSFs) regulate HSP 
transcription but also are not differentially expressed (40,41). HSF activity can be 
modulated via nuclear localization and post-translational modifications and were not 
examined in this study (40,41). While it cannot be excluded that stress response deviates 
in MNR and intolerant MNR through protein interaction with heat shock proteins, the 
underlying cause of cellular stress was not implicated with the gene expression data. 
 
Despite changes in genes regulating lipid metabolism, no differences were observed in 
hepatic cholesterol or serum cholesterol and triglycerides in these adult MNR offspring 
on standard chow (10). Offspring of maternal protein restriction in rats are more sensitive 
to dietary-induced obesity and insulin resistance and have altered transcription of 
cytochrome p450 gene family members (42). Altered expression of lipid metabolism-
related genes could indicate that MNR offspring are more sensitive to a high-caloric diet 
in adulthood. However, the absence of dyslipidemia in standard chow-fed offspring 
suggests genes regulating lipid metabolism are not likely the mechanism of glucose 
intolerance in this study. 
 
Few genes were differentially expressed in muscle and adipose tissue between maternal 
nutrition or glucose tolerance groups. Differential gene expression in response to 
maternal nutrition or growth restriction in fat pads and skeletal muscles have been 
previously documented (43,44). It is possible that quadriceps femoris and perigonadal fat 
pads are less sensitive to maternal nutrition than subcutaneous fat and biceps femoris 
muscle that were used in previous studies (43,44). Maternal nutrient restriction may have 
also had a greater impact on the tissues if it was reduced more than 30%. Although in 
rats, even 50% MNR resulted in transcriptional changes in the fetal liver but not adipose 
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tissue and skeletal muscle, suggesting the muscle and adipose tissue could be more 
resistant to maternal diet (29). The absence of short and long-term impacts on gene 
expression in adipose and skeletal muscle may relate to developmental timing. In rodents 
and humans both of these tissues continue to develop into the postnatal period (45,46). 
 
MNR offspring that had impaired glucose tolerance or higher fasting blood glucose levels 
also have similar gene expression in the liver, fat and muscle compared to controls. 
Similar expression suggests that fetal adaptations do not result transcriptome changes in 
metabolic genes that persist into adulthood, at least in liver, skeletal muscle and adipose 
tissue. Therefore, persistent gene expression changes are not likely the mechanism behind 
the altered adult metabolism in this model of IUGR. Maternal diet or fetal growth 
restriction can influence genomic stability, body mass composition, gut microbiome, and 
transcription in other tissues such as the pancreas in offspring which could mediate long 
term metabolism (47–50). Future studies are needed to identify alternate mechanisms 
mediating effects of reduced maternal nutrition on susceptibility to aberrant glucose 
metabolism in this model of growth restriction. 
 
 
 
103 
 References 
1.  Han VKM, Seferovic MD, Albion CD, Gupta MB  (2012) Intrauterine Growth 
Restriction: Intervention Strategies. In: Buonocore G., Bracci R., Weindling M. 
(eds) Neonatology. Springer, Milano, p. 89-93. 
2.  Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity 
and mortality among premature neonates. American Journal of Obstetrics and 
Gynecology. 2004;191:481–7.  
3.  Morrison KM, Ramsingh L, Gunn E, et al. Cardiometabolic Health in Adults 
Born Premature With Extremely Low Birth Weight. Pediatrics. 
2016;138:e20160515.  
4.  Ravelli AC, van der Meulen JH, Michels RP, et al. Glucose tolerance in adults 
after prenatal exposure to famine. Lancet 1998;351:173–7.  
5.  Hales CN, Barker DJP. Type 2 (non-insulin-dependent) diabetes mellitus: the 
thrifty phenotype hypothesis. Int J Epidemiol. 2013;42:1215–22.  
6.  Roseboom TJ, van der Meulen JH, Ravelli AC, et al. Blood pressure in adults 
after prenatal exposure to famine. J Hypertens. 1999;17:325–30.  
7.  Oliveira D, Cezar J, Gomes RM, et al. Protein Restriction During the Last Third 
of Pregnancy Malprograms the Neuroendocrine Axes to Induce Metabolic 
Syndrome in Adult Male Rat Offspring. Endocrinology. 2016;157:1799–812.  
8.  Chamson-Reig A, Thyssen SM, Hill DJ, Arany E. Exposure of the Pregnant Rat 
to Low Protein Diet Causes Impaired Glucose Homeostasis in the Young Adult 
Offspring by Different Mechanisms in Males and Females. Exp Biol Med 
(Maywood). 2009;234:1425–36.  
9.  Barker DJ. The fetal and infant origins of adult disease. BMJ. 1990;301:1111.  
 
 
 
104 
10.  Radford BN, Han VKM. Offspring from maternal nutrient restriction in mice 
show variations in adult glucose metabolism similar to human fetal growth 
restriction. J Dev Orig Health Dis. 2018. doi: 10.1017/S2040174418000983.  
11.  Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 
2017;23:804–14.  
12.  Langmead B,  Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat. 
Methods. 2012;9:357-359. 
13.  R Core Team (2013). R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-
project.org/. 
14.  Palarea-Albaladejo J, Martín-Fernández JA. zCompositions — R package for 
multivariate imputation of left-censored data under a compositional approach. 
Chemometrics and Intelligent Laboratory Systems. 2015;143:85–96.  
15.  Gloor GB, Reid G. Compositional analysis: a valid approach to analyze 
microbiome high-throughput sequencing data. Can J Microbiol. 2016;62:692–
703.  
16.  Gloor GB, Wu JR, Pawlowsky-Glahn V, Egozcue JJ. It’s all relative: analyzing 
microbiome data as compositions. Ann Epidemiol. 2016;26:322–9.  
17.  Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-
Verlag; 2016.  
18.  Gierliński M, Cole C, Schofield P, et al. Statistical models for RNA-seq data 
derived from a two-condition 48-replicate experiment. Bioinformatics. 
2015;31:3625–30.  
19.  Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for 
differential expression analysis of digital gene expression data. Bioinformatics. 
2010;26:139–40.  
 
 
 
105 
20.  Love MI, Huber W, Anders S. Moderated estimation of fold change and  
dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.  
21.  Fernandes AD, Macklaim JM, Linn TG, Reid G, Gloor GB. ANOVA-like 
differential expression (ALDEx) analysis for mixed population RNA-Seq. PLoS 
ONE. 2013;8:e67019.  
22.  Mi H, Thomas P. PANTHER Pathway: An Ontology-Based Pathway Database 
Coupled with Data Analysis Tools. Methods Mol Biol. 2009;563:123–40. 
23.  Mi H, Huang X, Muruganujan A, et al. PANTHER version 11: expanded 
annotation data from Gene Ontology and Reactome pathways, and data analysis 
tool enhancements. Nucleic Acids Res. 2017;45:D183–9.  
24.  Chen EY, Tan CM, Kou Y, et al. Enrichr: interactive and collaborative HTML5 
gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.  
25.  Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set 
enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90-
97.  
26.  Matsumoto M, Kondo K, Shiraki T, et al. Genomewide approaches for BACH1 
target genes in mouse embryonic fibroblasts showed BACH1-Pparg pathway in 
adipogenesis. Genes Cells. 2016;21:553–67.  
27.  Stahel P, Sud SK, Lee SJ, et al. Phenotypic and genetic analysis of an adult cohort 
with extreme obesity. Int J Obes (Lond). 2018; 
28.  Tiwary S, Morales JE, Kwiatkowski SC, Lang FF, Rao G, McCarty JH. 
Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid 
Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid 
Transporter Mfsd2a. Sci Rep. 2018;8:8267.  
29.  Nowacka-Woszuk J, Szczerbal I, Malinowska AM, Chmurzynska A. 
Transgenerational effects of prenatal restricted diet on gene expression and 
histone modifications in the rat. PLoS ONE. 2018;13:e0193464.  
 
 
 
106 
30.  Freije WA, Thamotharan S, Lee R, Shin B-C, Devaskar SU. The hepatic 
transcriptome of young suckling and aging intrauterine growth restricted male 
rats. J Cell Biochem. 2015;116:566–79.  
31.  Perez VJ, Eatwell JC, Samorajski T. A metabolism chamber for measuring 
oxygen consumption in the laboratory rat and mouse. Physiol Behav. 
1980;24:1185–9.  
32.  Drabsch T, Holzapfel C, Stecher L, Petzold J, Skurk T, Hauner H. Associations 
Between C-Reactive Protein, Insulin Sensitivity, and Resting Metabolic Rate in 
Adults: A Mediator Analysis. Front Endocrinol (Lausanne). 2018;9:556.  
33.  Vaiman D, Gascoin-Lachambre G, Boubred F, et al. The intensity of IUGR-
induced transcriptome deregulations is inversely correlated with the onset of 
organ function in a rat model. PLoS ONE. 2011;6:e21222.  
34.  Sohi G, Revesz A, Hardy DB. Nutritional mismatch in postnatal life of low birth 
weight rat offspring leads to increased phosphorylation of hepatic eukaryotic 
initiation factor 2 α in adulthood. Metab Clin Exp. 2013;62:1367–74.  
35.  Mosser DD, Caron AW, Bourget L, et al. The chaperone function of hsp70 is 
required for protection against stress-induced apoptosis. Mol Cell Biol. 
2000;20:7146–59.  
36.  Gupte AA, Bomhoff GL, Morris JK, Gorres BK, Geiger PC. Lipoic acid increases 
heat shock protein expression and inhibits stress kinase activation to improve 
insulin signaling in skeletal muscle from high-fat-fed rats. J Appl Physiol. 
2009;106:1425–34.  
37.  Hulina-Tomašković A, Heijink IH, Jonker MR, Somborac-Bačura A, Grdić 
Rajković M, Rumora L. Pro-inflammatory effects of extracellular Hsp70 and 
cigarette smoke in primary airway epithelial cells from COPD patients. 
Biochimie. 2018;156:47–58.  
 
 
 
107 
38.  Rodrigues-Krause J, Krause M, O’Hagan C, et al. Divergence of intracellular and 
extracellular HSP72 in type 2 diabetes: does fat matter? Cell Stress Chaperones. 
2012;17:293–302.  
39.  Li J, Fu X, Cao S, et al. Membrane-associated androgen receptor (AR) potentiates 
its transcriptional activities by activating heat shock protein 27 (HSP27). J Biol 
Chem. 2018;293:12719–29.  
40.  Larson JS, Schuetz TJ, Kingston RE. Activation in vitro of sequence-specific 
DNA binding by a human regulatory factor. Nature. 1988;335:372–5.  
41.  Green M, Schuetz TJ, Sullivan EK, Kingston RE. A heat shock-responsive 
domain of human HSF1 that regulates transcription activation domain function. 
Mol Cell Biol. 1995;15:3354–62.  
42.  Sohi G, Marchand K, Revesz A, Arany E, Hardy DB. Maternal protein restriction 
elevates cholesterol in adult rat offspring due to repressive changes in histone 
modifications at the cholesterol 7alpha-hydroxylase promoter. Mol Endocrinol. 
2011;25:785–98.  
43.  Soto SM, Blake AC, Wesolowski SR, et al. Myoblast replication is reduced in the 
IUGR fetus despite maintained proliferative capacity in vitro. J Endocrinol. 
2017;232:475–91.  
44.  Peñagaricano F, Wang X, Rosa GJ, Radunz AE, Khatib H. Maternal nutrition 
induces gene expression changes in fetal muscle and adipose tissues in sheep. 
BMC Genomics. 2014;15:1034.  
45.  White RB, Biérinx A-S, Gnocchi VF, Zammit PS. Dynamics of muscle fibre 
growth during postnatal mouse development. BMC Dev Biol. 2010;10:21.  
46.  Holtrup B, Church CD, Berry R, et al. Puberty is an important developmental 
period for the establishment of adipose tissue mass and metabolic homeostasis. 
Adipocyte. 2017;6:224–33.  
 
 
 
108 
47.  Soderborg TK, Clark SE, Mulligan CE, et al. The gut microbiota in infants of 
obese mothers increases inflammation and susceptibility to NAFLD. Nat 
Commun. 2018;9:4462.  
48.  Tarry-Adkins JL, Fernandez-Twinn DS, Chen JH, et al. Poor maternal nutrition 
and accelerated postnatal growth induces an accelerated aging phenotype and 
oxidative stress in skeletal muscle of male rats. Dis Model Mech. 2016;9:1221–9.  
49.  Souza AP de, Pedroso AP, Watanabe RLH, et al. Gender-specific effects of 
intrauterine growth restriction on the adipose tissue of adult rats: a proteomic 
approach. Proteome Science. 2015;13:32.  
50.  Deyssenroth MA, Peng S, Hao K, Lambertini L, Marsit CJ, Chen J. Whole-
transcriptome analysis delineates the human placenta gene network and its 
associations with fetal growth. BMC Genomics. 2017;18:520.  
 
 
 
 
109 
Chapter 6 : Discussion 
 Summary and Prospective 
 MNR as a Model for Metabolic Changes Associated with 
IUGR 
We demonstrated in this study that moderate maternal nutrient restriction during 
gestation in CD-1 mice resulted in fetal growth restriction and was associated with 
changes in glucose metabolism of adult male offspring. Reduced fetal and liver size was 
associated with increased hepatic transcription of genes in chronic hypoxia signalling. At 
6-months, most male MNR offspring have increased hepatic insulin sensitivity and about 
20% develop glucose intolerance. However, no changes in metabolically regulatory 
transcripts were detected in 6-month adipose tissue, skeletal muscle and right medial liver 
lobe. This suggested that in this model, fetal liver adaptations could be mediated by 
transcription changes, but long-term alterations in glucose metabolism are not induced by 
differential expression of metabolically regulatory genes in the liver, skeletal muscle and 
adipose tissue. 
 
The model can be used to study adaptations in response to pathological IUGR resulting 
from fetal undernutrition in humans. Reduced nutrition is one adversity which is common 
in placental insufficiency and maternal malnutrition (1). Clinically, IUGR is defined as a 
pregnancy condition in which the estimated weight of the fetus is less than 10th percentile 
expected for gestational age and an infant born from these pregnancies is termed small 
for gestational age (SGA). However, infants can experience reduced nutrition, growth 
restriction and metabolic adaptations, and have a birth weight greater than 10th percentile. 
Clinically, these infants will not be identified as SGA, however, they are impacted 
similarly to those who are SGA from IUGR pregnancies. Since long-term human studies 
are challenging to conduct, we developed this model in mice to follow the offspring 
within a feasible time frame (6 months) to conduct tissue-specific gene expression and 
epigenetic studies. It was our expectation that the model of maternal nutrient restriction in 
mice would allow investigations into molecular mechanisms that underlie long-term 
morbidity in a number of tissues. In nutrient restriction models of IUGR, all offspring 
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experience reduced nutrition during fetal life. Therefore, the model provides an 
opportunity to investigate offspring that result in low birth weight as well as those who 
do not. Immediate and long-term adaptations in response to fetal undernutrition would be 
applicable to health outcomes of the newborns as well as in later life and include infants 
encompassed and missed by the current clinical definition of IUGR. 
 
Individuals born low birth weight, often used as a proxy for fetal growth restriction 
(FGR) or intrauterine growth restriction (IUGR), are 1.4 times more likely to develop 
type 2 diabetes as adults (2). Although at greater risk, not all of these infants will develop 
type 2 diabetes. Results from this model indicate that maternal nutrient restricted 
offspring with similar genetic backgrounds, maternal nutrition, and postnatal diet develop 
variable glucose metabolism as adults. This model provides susceptible and non-
susceptible IUGR populations, which can be used to understand fetal adaptations that 
may increase or decrease risk for adult glucose intolerance. 
 
‘Catch-up’ growth, especially high growth rates in the first week of life in rodents (3,4) 
or infancy/early childhood in humans (5), is associated with a more aberrant adult 
metabolism; and prevention of early post-natal ‘catch-up’ is suggested to be 
metabolically protective (4). Due to the rapid period of ‘catch-up’ growth in mice, it is 
difficult to calculate growth rates between birth and day 3. While it is possible that 
variations in catch-up growth could contribute to differences in susceptibility, it is 
unlikely due to the short period of time in which it occurs. 
 
Fetal implantation site may also contribute to degree of growth restriction in MNR 
offspring. The main blood supply to the uterus is located at the periphery and at the 
uterine horn (6). Fetuses implanted further away from the blood supply would have 
experienced greater fetal undernutrition than pups closer to the blood supply. In our 
study, no correlations between fetal weight at E18.5 and the site of implantation were 
found. Subsequently, birth weight could not be used to estimate distance from the blood 
supply but could contribute to variations within litters. 
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CD-1 mice used in this model are an outbred strain and contain more genetic variability 
relative to inbred strains. In humans, genetic polymorphisms such as a glycine to arginine 
transition at codon 972 of IRS-1 are associated with insulin resistance and type II 
diabetes (7). In mice, wild-type C57BL/6 develop diet-induced fatty liver but CD-1 do 
not (8). However, strains produced from inbreeding CD-1 are susceptible to glucose 
intolerance and obesity, indicating genes mediating adult metabolism exist in this 
population (9). Such genetic variation likely contributes adult glucose metabolism in 
response to fetal nutrition.  
  
In both the fetal and the adult tissues studied, the liver was the most vulnerable to 
alterations in maternal nutrition. When protein is reduced in maternal diet, fetal liver 
weight is decreased relative to body weight (10). Small for gestational age infants also 
have reduced liver weight compared to appropriate for gestational age infants (11). In this 
model, both fetal and adult livers were reduced relative to body mass. Although not 
measured in fetal livers, adult MNR offspring had increased insulin sensitivity. Insulin 
signalling regulates pathways such as hepatic glucose output, glycogen synthesis and 
mitogenesis, influencing glucose metabolism and hepatic growth. Additionally, 
transcriptomic changes were most evident in the liver of adults relative to adipose tissue 
and skeletal muscle, especially among the MNR that were glucose intolerant. Maternal 
nutrient restriction in rats also resulted in hepatic transcriptional changes to epigenetic 
machinery with minimal changes in skeletal muscle and adipose tissue (12). In agreement 
with previous work, liver was sensitive to alterations in maternal nutrition, impacting 
liver size, gene expression and metabolism.  
 
Increased insulin sensitivity developed in response to fetal hypoinsulinemia in SGA 
infants and growth restricted models and contribute to hypoglycemia early in life (13–
15). Increased insulin sensitivity promotes tissues such as the skeletal muscle to take up 
and store glucose (14). This energy storage can cause rapid catch-up growth (13) which is 
associated visceral adiposity in humans (16). Both ectopic lipid accumulation and 
adiposity are risk factors for cardiometabolic disease (17). Unpublished work in our lab 
measured serum insulin during GTT and serum blood glucose in E18.5 fetuses, and have 
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demonstrated reduced insulin secretion and hypoglycemia also occur in the MNR fetus. 
While increased sensitivity continues at 6 months in most MNR, relatively higher serum 
insulin-to-glucagon ratios in intolerant MNR suggests that insulin resistance may have 
developed in the susceptible population. 
 Interaction between Maternal Nutrition and Postnatal Diet 
It is well known that overnutrition and poor dietary quality can result in obesity, insulin 
resistance and glucose intolerance. Dietary and exercise intervention can be used to 
prevent glucose intolerant populations from becoming type II diabetics (18). The timing 
of obesity also influences risk for metabolic disorders. Obesity in children at puberty or 
later had a positive association with type II diabetes (19). However, children that were 
obese at age 7, but achieved and maintained a healthy body weight by puberty, had a 
similar risk as the population that was not obese (19). Postnatal diets can enhance or 
impair detrimental effects in offspring from maternal nutritional insults. Specifically, 
continued calorie restriction after birth can prevent aberrant metabolic outcomes, and 
overnutrition or poor dietary quality can exaggerate the maladaptive impacts of fetal 
undernutrition on adult metabolism (20). This is thought to occur because the fetus adapts 
to a nutrient restrictive environment, and when postnatal food is abundant adaptations 
promoting energy conservation rather than expenditure are no longer an advantage. 
 
Contrary to other models of growth restriction demonstrating increased susceptibility to 
diet-induced obesity and metabolic disorders, a HFHS post-weaning diet did not result in 
a difference between control and MNR offspring in the metabolic parameters measured. 
Often these diets are high-fat rather than high-fat high-sugar (3). HFD and growth 
restriction in rats impaired beta cell survival independently (21). When HFD and growth 
restriction were combined, islet damage was not cumulatively worse, suggesting that 
growth restriction and calorie dense diets could converge on similar mechanisms (21). 
Additionally, although some controversy exists on whether high-sugar or high-fat diets 
are more detrimental, most studies agree that excess calories is one of the main factors 
contributing to metabolic health. In this study, mice on the HFHS diet ate less food (in 
grams) and resulted in a similar calorie intake as standard chow-fed offspring. Similar to 
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our study, male, but not female, rat offspring from maternal protein restriction on a HFD 
ate less (in grams), resulting in an isocaloric diet (22). While this dietary challenge did 
not vary based on maternal nutrition, all offspring developed and a reduced glucose 
tolerance and increased body weights. These data indicate an importance in dietary 
quality in determining adult metabolism. It is possible that a high-fat diet or high caloric 
diet would have different impacts on control and MNR adult glucose metabolism. 
However, isocaloric high-fat high-sugar post-weaning diet did not increase MNR 
susceptibility to metabolic disorders relative to controls. 
 Gene Expression Changes in Offspring Associated with 
Maternal Nutrition and Adult Glucose Metabolism 
In this study, gene expression was analyzed by three common differential expression 
tools, DESeq2, EdgeR and Aldex2, that perform well in synthetic and real RNAseq data 
sets (23,24). Genes were considered differentially expressed if they were detected by two 
or more tools. This approach was taken because no ‘gold standard’ for differential gene 
expression exists. In all three tools, counts are normalized or transformed to control for 
differences in library size and composition. Following normalization or transformation, 
the counts were fitted to a model and statistical comparisons between groups and multiple 
testing corrections were done. However, each program uses different approaches for 
these steps (Table 6.1.1). Quin et al. (2018), recently compared the precision 
(minimizing false positives) and recall (true positives) between all three software (24). 
The authors found Aldex2 had high precision but low recall for studies with < 10 
samples, and that EdgeR and DESeq2 have more sensitivity for this range of replicates 
(24). Although their study used the Wilcox Rank test in Aldex2 which would have lower 
power than the Welch’s test used in this study for few replicates (25). Still, with 7-9 
replicates per group few differentially expressed genes were detected by Aldex2 likely 
due to the limited statistical power of the non-parametric test. Focusing on genes that 
were differentially expressed in multiple tools may address the reproducibility issues 
found with RNA sequencing studies, and was the approach taken in this study. 
 
To identify genes associated with fetal adaptations and adult metabolism, the 
transcriptome of liver, skeletal muscle and adipose tissue in adult mice and fetal liver 
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were analyzed. Genes that were differentially expressed, particularly those changed in 
both the fetus and the adult, could be mediate fetal adaptations and maladaptive changes 
that influence adult glucose metabolism. Because changes in glucose metabolism were 
only detected in standard chow-fed adult offspring, adult expression was only examined 
on this diet.  
 
In the liver of MNR fetuses, differentially expressed genes were involved in overlapping 
regulation of various transcription factors (Figure 6.1.1). However, hypoxia-induced 
signalling was the primary pathway with changes up- and down-stream of the 
transcription factors. Additionally, with moderate fold change in transcription and 
significant enrichment with multiple pathway enrichment tools, we focused on the 
cumulative change in HIF signalling.  
 
Growth restriction caused by reduced maternal nutrition and maternal hypoxia result in 
similar fetal and placental adaptations. Increased placental size, more efficient 
vasculature, and no changes in placental hypoxia, suggest that both hypoxic and nutrient 
restricted placentas are able to compensate (29–31). Despite placental adaptations, 
hypoxia and MNR cause fetal circulation to redistribute oxygenated blood from the 
umbilical cord away from the liver and to the brain (32,33). In growth restricted humans, 
blood flow from the umbilical cord is reduced to both liver lobes, but the reduction is 
greater to the right and is the portion of the liver examined in this study (34). 
Additionally, glucose deprivation in colon cancer cell lines can induce hypoxia signalling 
(35,36), suggesting fetal nutrient availability may also be modulating HIF signalling in 
MNR offspring. Increased HIF-2a and HIF-3a transcripts and protein, and increased 
transcription of HRE-containing genes in this study support evidence of hypoxia 
signalling in MNR fetal liver. Further studies need to be done to understand whether 
redistribution of fetal circulation and/or nutritional regulation cause the induction of 
hypoxia-inducible signaling in response to maternal nutrition. Regardless of the 
mechanism, maternal hypoxia and MNR could induced the HIF pathway in the right 
lobes of the liver and contribute to similar adaptations in offspring. 
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Hypoxia signalling is involved in the regulation of metabolism, pluripotency and 
differentiation of progenitor cell populations and angiogenesis (37,38), which are 
important pathways tightly regulated in tissue development. Increased HIF-2a and HIF-
3a are associated with chronic hypoxia and the switch from HIF-1a to HIF-2a occurs in 
developing tissue when vascularity and oxygen tension increase (39,40). Tissue sampling 
late in gestation, when the HIF-1a to HIF-2a switch may have occurred, likely contribute 
to the detection of HIF-2a but not HIF-1a. Additionally, the prolonged exposure of the 
fetus to nutrient restriction in this model could result in chronic hypoxia signalling and 
mediate an increase in HIF-2a and HIF-3a protein. 
 
HIF-1a transcriptional targets were initially thought to be involved in promoting 
glycolytic metabolism and HIF-2a targets in fatty acid oxidation and matrix remodeling. 
(41,42). Both HIF-1a and HIF-2a regulate angiogenesis(42). Gene expression in 
neuroblastoma cells exposed to acute hypoxia and to chronic or moderate hypoxia were 
similar suggesting that the number of HIF redundant targets may be less than initially 
cited, and that conflicting evidence might be confounded by the temporal regulation of 
HIF-1a or HIF-2a (39). Additionally, Kdm3a, Ccng2, Hif-3a and Pfkfb3 were induced 
with both HIF-2a and HIF-1a overexpression in human umbilical vein endothelial cells 
(42). Subsequently, hypoxia inducible genes were not sorted based on HIF-1a or HIF-2a 
targets in the literature. 
 
HIF-dependent hypoxia inducible transcripts increased in MNR were involved in 
metabolic (PFKFB3, FKBP5) and direct (KDM3a) or indirect (FKBP5) epigenetic 
responses. Enhanced expression of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 
3 (PFKFB3) promotes glycolysis and could influence hepatic glycogen (43). FKBP5 is 
associated with insulin resistance through inhibition of glucocorticoid signalling and as a 
co-chaperone to the Akt phosphatse, PHLPP(44,45). Both glucocorticoids and insulin 
promote glycogen deposition in the liver (46). While transcript levels were increased, 
protein changes were not significant suggesting these adaptations were not sufficient in 
preventing glycogen depletion during MNR fetal hypoglycemia. Near birth fetal 
metabolism in the liver shifts from glycolytic to gluconeogenic which may also indicate a 
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delay in this shift in MNR male offspring (47).  Reduced liver size, increased hypoxia 
signaling, as well an increased marker of proliferation and reduced glycogen identified in 
this model, suggests that MNR have immature livers at E18.5.  
 
Differential expression of genes involved in the regulation of epigenetic machinery 
provide a mechanism for long-term impacts of fetal undernutrition. In neural cells, 
FKFBP5 increase is negatively associated with global methylation by competitively 
inhibiting FKBP52 recruitment and reducing DNTM1 efficiency (48). KDM3a is a 
histone methyl transferase which removes mono and di-methylation at histone 3 lysine 9, 
typically associated with heterochromatin, especially at HRE-containing genes(49). 
Increased transcription of both modifiers could suggest epigenetic changes are 
influencing fetal transcription at HRE and non-HRE-containing genes and require further 
studies.   
 
Although increased transcription of genes induced by HIFs were detected, the increase 
was moderate and not significantly reflected at the protein level. HIF-3a has been shown 
to weakly induce some HRE-containing genes, but most functional evidence suggests a 
role in repression of HIF-1/2a-dependent transcription (50,51). Increased HIF-3a might 
be repressing the transcriptional activity of HIF-2a and the magnitude of hypoxia 
response in MNR offspring. In MNR in guinea pigs, increased hepatic EPO protein were 
only significantly different in females suggesting that female fetuses may adapt with 
increased erythropoiesis (30). Although females were not examined in this study, it is 
possible that the hypoxic response in males is more moderate and could be mediated 
through HIF-3a.  
 
Hypoxic gene expression changes were not detectable in MNR adult livers. In fact, few 
transcriptional changes were detected in liver, skeletal muscle and adipose tissue. 
Maternal nutrient restriction in rats resulted in alterations in fetal epigenetic machinery 
but histone acetylation changes did not persist to 4 weeks (12). Additionally, the number 
of genes impacted was reduced over time, despite metabolic changes becoming more 
evident with age (52). However, if fetal undernutrition during pregnancy established 
differences in cell populations and/or differences in how the cells are functioning, 
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changes in gene expression would be expected. Consequently, although these adaptations 
may occur, they do not persist and are not likely the mechanism underlying changes in 
glucose metabolism in this model.  
 
It should be noted most changes in glucose metabolism were only detected in stress 
conditions, such as glucose tolerance and insulin challenge tests. Fetal hepatic changes 
were detected when the stress of nutrient restriction was still evident and altered HIF 
signaling might be evident in MNR offspring during a glucose or insulin challenge. In 
chronic myeloid leukemia patients, VHL loss-of-function mutations result in changes to 
methylation at HRE-promoters but do not result in increased HIF signaling until a 
‘second hit’ occurs (53). The differential priming of HRE-genes in these individuals 
increase anti-apoptotic and angiogenic responses in the tumor (53). While differences in 
VHL were not confirmed in the validation cohort, KDM3a and FKBP5 were increased. It 
cannot be excluded that the transcription during stressed conditions could vary in HIF or 
other stress response pathways in tissues of MNR adult offspring. 
 
Intrauterine fetal adaptations to moderate nutrition restriction could also be independent 
of changes in cell populations or persistent epigenetic changes. Evidence of altered gut 
microbiome and reduced genomic stability have been observed in response to different 
maternal diets (54,55). Protein function and stability can also be regulated by genetic 
polymorphisms and miRNAs. Lastly, tissues not yet examined in this model could have 
influenced fetal adaptations and modulated susceptibility in the MNR population.  
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Table 6.1.1 Comparison of tools used for differential expression 
Tool Normalization/ 
Transformation 
Statistical analysis Model of 
Count 
Means 
Multiple 
comparisons 
adjustments 
Outlier 
Detection 
Reference 
DESeq2 
• Normalize with a 
scaling factor 
 
• Median of ratios to 
the geometric 
mean 
Empirical Bayes 
estimation of 
dispersion and log 
fold change for the 
Wald test 
(parametric) 
Negative 
binomial 
Benjamini-
Hochberg 
correction 
Cooks 
Distance 
(>99th 
percentile) 
for ³ 7 
samples 
(26) 
EdgeR 
• Normalized with a 
scaling factor 
 
• Weighted mean of 
ratios in a pairwise 
comparison of 
each sample and a 
reference sample 
Empirical Bayes 
estimation of 
dispersion and an 
adapted Fisher’s 
exact test 
(parametric) 
Negative 
binomial 
Benjamini-
Hochberg 
correction 
None (27) 
Aldex2 
• Transformed by 
the centered log 
ratio (clr) 
Empirical Bayes to 
estimate Monte 
Carlo Dirichlet 
instances and 
Welch’s test (non-
parametric) 
Poisson 
distribution 
Benjamini-
Hochberg 
correction 
None (25,28) 
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Figure 6.1.1 Genes differentially expressed up- and down-stream of transcription 
factors in fetal hepatic liver.  
Differential expression was detected upstream from many transcription factors (indicated 
by the grey bar) important in tissue development and metabolism. However, genes 
involved in hypoxia-inducible factor signalling were differentially regulated up- and 
downstream from HIF transcription factors.  
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 Limitations and Future Studies 
This the first in-depth use of maternal nutrient restriction post-implantation to birth in 
CD-1 mice to study the association between reduced fetal nutrition and long-term 
metabolic outcomes. While metabolic and expression changes identified in this study 
provide insight for understanding the relationship between maternal nutrition and fetal 
adaptations, there are also associated limitations that can be addressed with further 
studies. 
 Further Characterization of Metabolic and Expression 
Outcomes in MNR Offspring 
Increased PAI-1 and resistin in MNR serum could indicate increased fat mass or meta-
inflammation. However, mRNA of PAI-1 and resistin were not different in MNR adipose 
tissue compared to controls. Transcripts in inflammatory pathways were also similar in 
control and MNR adipose tissue, suggesting increased fat mass rather than adipocyte 
meta-inflammation in MNR offspring. Reduced lean mass been associated with other 
models of MNR and can contribute to decreased glucose tolerance (56). In animal 
studies, the ‘gold method’ is via chemical carcass analysis which is terminal and requires 
the entire carcass (57). Micro-CT imaging is accessible to our lab, can be done on live 
specimens, distinguishes between subcutaneous and visceral adipose tissue, and provide 
accurate estimate of body mass composition in mice (58,59). Utilizing this technology in 
adult offspring would determine whether body mass composition is different in MNR 
offspring and allow metabolic and expression analysis in the same mouse.  
 
Insulin sensitivity was only measured in a portion of the cohort due to technical 
limitations in the hepatic portal vein insulin challenge. The most accurate and sensitive 
method for tissue-specific and whole-body insulin sensitivity is hyperinsulinemic 
euglycemic clamp studies. While this method can be performed on a large sample 
number, it is technically challenging, requires expensive equipment, and is difficult to 
analyze. If the equipment or expertise were available, this technique could be used. 
Alternatively, injection of insulin or saline and collecting tissues could be done in all 
animal of a cohort after 6-month glucose tolerance testing. Similar to the gene expression 
analysis in this study, tolerant, intolerant and average controls could be used to detect 
pAKT to AKT ratios. While the sample size per group would not increase with this 
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design, tissue-specific insulin sensitivity could be quantified for intolerant MNR relative 
to control and tolerant MNR populations. 
 
During the insulin challenge test or hyperinsulinemic euglycemic clamp study, liver, 
adipose tissue and skeletal muscle could also be collected for gene expression analysis. 
Studies in humans show that hyperglycemia and hyperinsulinemia initiate gene 
expression changes in many tissues (60,61). Additionally, insulin-induced gene 
expression in the skeletal muscle and adipose tissues during hyperinsulinemic clamp 
studies were blunted in type 2 diabetics compared to controls, despite having similar 
basal expression (60). To our knowledge, gene expression in adult offspring from growth 
restricted models have not been examined after a glucose or insulin bolus. This would 
assess whether adaptations are present in MNR offspring in metabolic ‘stress’ conditions. 
 Influence of Reduced Nutrition in Gestation and 
Throughout Lactation of Skeletal Muscle and Adipose 
Tissue 
In addition to examining changes in gene expression during hyperinsulinemia, extending 
nutrient restriction until weaning could also influence long term impacts. With the current 
model, skeletal muscle and adipose tissue had few differentially expressed genes. In mice 
the number of muscle fibers is determined around day 7 and the number of myonuclei by 
day 21 (62). Establishment of white adipose tissue occurs in two phases, the first from 
birth to two weeks of life and the second in puberty (around weaning) (63). Although 
hyperplasia and hypertrophy of white adipose tissue continue throughout life, the rate of 
increase is steady through adulthood (63). The offspring in this study were fostered to ad 
libitum-fed mothers, receiving ad libitum for the postnatal developmental periods. 
Extension of nutrient restriction throughout lactation would provide further insight into 
the effects of reduced nutrition on development of these tissues. However, it may also 
modify ‘catch-up’ growth and adult metabolism (64). Extending nutrient restriction to 
weaning would assess the interaction between MNR and nutrition during lactation and 
could increase impacts on skeletal muscle and adipose tissue. 
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 Mechanism of Fetal Hepatic Hypoxia in Adaptations to 
Growth Restriction 
The concept of hypoxia signalling in growth restricted infants is relatively new. Dynamic 
changes to hypoxic signalling suggest that the impact at different developmental stages 
could vary (37,65). Temporal analysis of hepatic HIF-1a, HIF-2a, and HIF-3a mRNA 
and protein during liver development in control and MNR offspring is needed. This study 
would determine if a switch from HIF-1a to HIF-2a occurs in the liver and whether the 
peak expression or stabilization vary between control and MNR. RNAseq at peak 
expression could provide insight into the changes mediated by altered HIF signalling in 
the MNR offspring. 
 
In addition to understanding the timing of HIF signalling, further experiments need to 
determine how increased hepatic hypoxia influences fetal adaptations to nutrient 
restriction. Knocking down and overexpressing fetal hepatic HIF-2a and HIF-3a, and 
HIF-1a if MNR influences protein levels earlier in gestation, during MNR would clarify 
whether increased HIF signalling is an advantage for fetal survival. Recombinant adeno-
associated virus (rAAV) injected into the amniotic sac with miRNA or expression vectors 
under the control of the alpha fetoprotein promoter would allow for such liver-specific 
fetal gene manipulation (66,67). Since differentially expressed genes in the fetus did not 
persistent into adult life, temporal knock down or overexpression is preferable. These 
studies would gain insight into the role of HIFs in liver development and fetal survival 
during undernutrition. It would also determine whether these adaptations mediate long 
term metabolic outcomes of the MNR offspring. 
 Overall Conclusions and Significance 
This study investigated fetal and adult adaptations in liver, adipose tissue and skeletal 
muscle of maternal nutrient restricted male offspring in mice on a post-weaning standard 
chow or a HFHS diet (Figure 6.3.2). Offspring from MNR pregnancies experienced fetal 
growth restriction and changes to adult glucose tolerance or insulin signalling. In the 
fetus, reductions in maternal calories disproportionately impacted the liver and might be 
mediated through increased hypoxia signalling. Differences in hypoxia-inducible 
transcripts did not persist to 6 months. As adults, minimal changes in gene expression in 
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all three tissues were detected. However, the liver of MNR offspring was smaller with 
increased insulin sensitivity. As adults, MNR was associated with increased serum 
peptide markers that suggest changes to body mass composition. Despite the changes in 
standard chow-fed offspring, no differences between MNR and controls on an isocaloric 
post-weaning HFHS diet were detected.  While liver weight, insulin sensitivity and 
potentially body mass composition are influenced by MNR, post-weaning diet overcame 
maternal nutrient effects.  
 
To our knowledge this is the first study of growth restriction where susceptible and non-
susceptible populations are examined in addition to changes occurring in all offspring. 
Despite having susceptible and non-susceptible adult populations in standard chow-fed 
offspring, metabolic and gene expression changes were only moderately impacted. Gene 
expression during metabolic stress could provide insight into variability in the MNR 
offspring. Additionally, serum peptide markers suggest body mass composition and 
appetite could be influencing susceptibility. Despite fetal liver adaptations and adult 
metabolic changes gene expression changes in metabolically regulatory genes were not 
differentially expressed.  
 
Understanding tissue-specific adaptations from reduced fetal nutrition and how they 
mediate adult glucose intolerance will provide insight into the increased risk for type 2 
diabetes in human growth restricted populations. Type 2 diabetes has significant 
complications and causes a substantial financial burden on the medical system (68). Early 
identification and prevention can reduce cost and improve patient quality of life. 
Identifying such adaptations will aid in recognizing, preventing and/or treating aberrant 
glucose metabolism in these individuals. Additionally, this study supports the notion that 
fetal nutrition is important in establishing adult liver metabolism which could impact 
chronic diseases beyond metabolic disorders.  
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Figure 6.3.1 Metabolic and expression changes in the male fetal and adult offspring 
from maternal nutrient restriction.  
In the fetus, body and liver weight is reduced (chapter 2) and transcripts in HIF signalling 
were induced (chapter 4). On standard chow, MNR offspring had increased hepatic 
insulin sensitivity, reduced liver weight and increased serum markers for adiposity 
relative to controls (chapter 2). 20% of the MNR offspring were susceptible to glucose 
intolerance (chapter 2) and had increased differentially expressed (DE) genes (chapter 5). 
Post-weaning HFHS diet did not differentially impact MNR and control offspring in the 
parameters measured in this study (chapter 3). 
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Appendix 1 
Chapter 2 Supplementary Figures 
 
Supplementary Figure S2.3.1. Fetal weight relative to distance from the uterine 
blood supply. Pups at position 1 are closest to the ovaries or cervix in the uterine horn. 
Control (green) and MNR (red) litters are represented by different shades. Weight did not 
significantly differ between according to position (p = 0.4).  
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Supplementary Figure S2.3.2 Pyruvate challenge tests in male MNR and control 
offspring at 6 month of age. (a) There were no significant differences in blood glucose 
from 0 to 120 min (p = 0.4). (b) Similar total AUC between control and MNR indicate no 
differences in hepatic glucose output (p = 0.3). Control N=5, MNR N=5 (1 pup/litter). 
Data are mean ± SEM (a). Asterisk represents a p < 0.05 with a repeated measures 
ANOVA (a) or unpaired t-test (b). 
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Supplementary Table 2.2.1. Litter sizes and sex ratios for litters included in pre- and 
postnatal studies. 
Study Type Maternal Nutrition Fraction of Males Litter Size 
Fetal 
Control 0.42 14 
Control 0.57 14 
Control 0.62 13 
Average 0.54 +/- 0.06 13.7 +/- 0.3 
MNR 0.57 14 
MNR 0.5 12 
MNR 0.27 11 
Average 0.45 +/- 0.09 12.33 +/- 0.8 
Postnatal 
Control 0.46 15 
Control 0.67 12 
Control 0.79 14 
Control 0.54 13 
Control 0.54 13 
Average 0.6 +/-0.06 13.4 +/- 0.5 
MNR 0.55 11 
MNR 0.45 11 
MNR 0.38 13 
MNR 0.46 13 
MNR 0.69 13 
MNR 0.62 13 
MNR 0.5 12 
MNR 0.3 13 
MNR 0.38 13 
MNR 0.75 12 
Average 0.51 +/- 0.46 12.4 +/- 0.3 
Note: No significant differences between control and MNR were observed with an 
unpaired t-test. Mean is expressed as +/- SEM.  
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Appendix 2 
Chapter 4 Supplementary Figures 
 
 
Supplementary Figure S4.3.3 HIF-1a protein in mouse fetal (E18.5) liver and 
placenta, and normoxic and hypoxic HeLa cells.  
HIF-1a was detected in the placenta and HeLa cells but was not detected in the liver. 
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Supplementary Table 4.3.1 Top 50 pathways arranged by fold change (FC) of genes 
in distribution 2 on principle component 1 enriched in GO pathways (FDR < 0.05). 
 GO pathway FC FDR 
1 regulation of response to nutrient levels (GO:0032107) 3.59 1.93E-02 
2 regulation of response to extracellular stimulus (GO:0032104) 3.59 1.92E-02 
3 zymogen activation (GO:0031638) 2.59 2.77E-02 
4 hippocampus development (GO:0021766) 2.29 3.29E-02 
5 limbic system development (GO:0021761) 2.22 1.28E-02 
6 homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) 2.14 1.43E-02 
7 cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742) 1.94 6.25E-03 
8 potassium ion transmembrane transport (GO:0071805) 1.93 2.45E-02 
9 cellular potassium ion transport (GO:0071804) 1.93 2.44E-02 
10 positive regulation of epithelial cell proliferation (GO:0050679) 1.88 4.85E-03 
11 visual perception (GO:0007601) 1.88 3.13E-02 
12 sensory perception of light stimulus (GO:0050953) 1.87 3.41E-02 
13 regulation of blood pressure (GO:0008217) 1.73 3.39E-02 
14 second-messenger-mediated signaling (GO:0019932) 1.63 1.70E-02 
15 regulation of epithelial cell proliferation (GO:0050678) 1.62 6.38E-03 
16 regulation of anatomical structure size (GO:0090066) 1.58 3.58E-04 
17 positive regulation of response to external stimulus (GO:0032103) 1.57 4.93E-02 
18 positive regulation of cellular component biogenesis (GO:0044089) 1.56 1.40E-03 
19 inorganic cation transmembrane transport (GO:0098662) 1.55 1.24E-02 
20 response to growth factor (GO:0070848) 1.55 1.21E-02 
21 cellular response to growth factor stimulus (GO:0071363) 1.53 2.13E-02 
22 cell-cell adhesion (GO:0098609) 1.53 2.83E-02 
23 cation transmembrane transport (GO:0098655) 1.53 1.22E-02 
24 axon development (GO:0061564) 1.53 3.97E-02 
25 regulation of cellular component size (GO:0032535) 1.53 1.97E-02 
26 inorganic ion transmembrane transport (GO:0098660) 1.53 1.20E-02 
27 forebrain development (GO:0030900) 1.52 3.26E-02 
28 metal ion transport (GO:0030001) 1.52 3.57E-03 
29 negative regulation of cell development (GO:0010721) 1.51 3.95E-02 
30 regulation of ion transmembrane transport (GO:0034765) 1.5 1.33E-02 
31 positive regulation of nervous system development (GO:0051962) 1.5 1.79E-03 
32 regulation of ion transport (GO:0043269) 1.49 5.61E-04 
33 positive regulation of neuron differentiation (GO:0045666) 1.49 2.09E-02 
34 regulation of metal ion transport (GO:0010959) 1.48 4.88E-02 
35 regulation of neuron differentiation (GO:0045664) 1.46 9.11E-04 
36 positive regulation of cell proliferation (GO:0008284) 1.46 6.76E-05 
37 muscle structure development (GO:0061061) 1.46 2.83E-02 
38 positive regulation of MAPK cascade (GO:0043410) 1.46 1.49E-02 
39 regulation of nervous system development (GO:0051960) 1.46 4.91E-05 
40 calcium ion homeostasis (GO:0055074) 1.45 4.34E-02 
41 negative regulation of cell proliferation (GO:0008285) 1.44 4.43E-03 
42 regulation of cellular component biogenesis (GO:0044087) 1.44 3.31E-04 
43 negative regulation of cell differentiation (GO:0045596) 1.44 2.67E-03 
44 divalent inorganic cation homeostasis (GO:0072507) 1.44 4.91E-02 
45 regulation of cell cycle process (GO:0010564) 1.44 1.46E-02 
46 regulation of cell cycle (GO:0051726) 1.43 3.07E-04 
47 cell proliferation (GO:0008283) 1.43 1.65E-02 
48 regulation of MAPK cascade (GO:0043408) 1.43 3.32E-03 
49 regulation of cell proliferation (GO:0042127) 1.43 1.39E-07 
50 positive regulation of secretion (GO:0051047) 1.43 3.87E-02 
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Supplementary Table 4.3.2 Counts and cluster membership per sample (k-means 
clustering, K=2) 
Condition Cluster Counts 
MNR 2 74305030 
Control 2 75865086 
Control 2 80360976 
MNR 2 80920037 
Control 2 81553460 
MNR 2 83508564 
Control 2 83775128 
MNR 2 84106928 
MNR 2 84462329 
MNR 2 85525474 
Control 2 86281726 
MNR 2 87068555 
Control 1 92585570 
MNR 1 98375605 
Control 1 99626219 
Control 1 105476459 
MNR 1 105755590 
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Supplementary Table 4.3.3 49 protein-coding genes differentially expressed in MNR 
E18.5 liver relative to controls (FDR < 0.1 in 2 or more tools). 
 Gene Symbol Gene Name 
DESeq2 EdgeR Aldex2 
FC FDR FC FDR FC FDR 
1 Lin28a lin-28 homolog A (C. elegans) -1.92 0.00 -6.03 0.00 NA NA 
2 Rnf169 ring finger protein 169 -1.78 0.00 -9.51 0.00 NA NA 
3 Chrna4 
cholinergic receptor, 
nicotinic, alpha 
polypeptide 4 
-1.61 0.00 -2.28 0.01 NA NA 
4 Angptl4 angiopoietin-like 4 -1.59 0.00 -2.49 0.01 NA NA 
5 Cited2 
Cbp/p300-interacting 
transactivator, with 
Glu/Asp-rich carboxy-
terminal domain, 2 
-1.52 0.00 -1.74 0.03 NA NA 
6 Ppargc1b 
peroxisome proliferative 
activated receptor, 
gamma, coactivator 1 
beta 
-1.50 0.02 -2.47 0.07 NA NA 
7 Echdc1 
enoyl Coenzyme A 
hydratase domain 
containing 1 
-1.46 0.00 -1.49 0.00 NA NA 
8 Kbtbd8 
kelch repeat and BTB 
(POZ) domain 
containing 8 
-1.37 0.01 -1.45 0.07 NA NA 
9 Atp2b2 
ATPase, Ca++ 
transporting, plasma 
membrane 2 
-1.31 0.00 -1.36 0.01 NA NA 
10 Cars cysteinyl-tRNA synthetase -1.29 0.03 -1.34 0.08 NA NA 
11 Wisp2 
WNT1 inducible 
signalling pathway 
protein 2 
-1.28 0.03 -1353.64 0.00 NA NA 
12 Mll1 
myeloid/lymphoid or 
mixed-lineage leukemia 
1 
1.15 0.00 1.15 0.10 NA NA 
13 Ppp1r15a 
protein phosphatase 1, 
regulatory (inhibitor) 
subunit 15A 
1.17 0.06 1.18 0.09 NA NA 
14 Capn10 calpain 10 1.19 0.00 1.19 0.08 NA NA 
15 Man2b2 mannosidase 2, alpha B2 1.19 0.00 1.19 0.08 NA NA 
16 Syne1 synaptic nuclear envelope 1 1.19 0.00 1.20 0.00 NA NA 
17 Rassf1 
Ras association 
(RalGDS/AF-6) domain 
family member 1 
1.22 0.01 1.23 0.05 NA NA 
18 Coro7 coronin 7 1.22 0.00 1.22 0.08 NA NA 
19 Kdm3a lysine (K)-specific demethylase 3A 1.22 0.00 1.23 0.08 NA NA 
20 Chd7 chromodomain helicase DNA binding protein 7 1.23 0.01 1.24 0.03 NA NA 
21 Mycbp2 MYC binding protein 2 1.23 0.00 1.23 0.00 NA NA 
22 Crls1 cardiolipin synthase 1 1.23 0.00 1.24 0.08 NA NA 
23 Cep170 centrosomal protein 170 1.26 0.00 1.27 0.06 NA NA 
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24 Maff 
v-maf 
musculoaponeurotic 
fibrosarcoma oncogene 
family, protein F (avian) 
1.26 0.02 1.28 0.10 NA NA 
25 Stard5 
StAR-related lipid 
transfer (START) 
domain containing 5 
1.28 0.00 1.29 0.02 NA NA 
26 Rabgef1 RAB guanine nucleotide exchange factor (GEF) 1 1.28 0.00 1.29 0.00 NA NA 
27 Hif3a hypoxia inducible factor 3, alpha subunit 1.29 0.01 1.32 0.03 NA NA 
28 Pex26 peroxisomal biogenesis factor 26 1.31 0.01 1.35 0.10 NA NA 
29 Vhl von Hippel-Lindau tumor suppressor 1.32 0.03 1.39 0.10 NA NA 
30 Inpp4a inositol polyphosphate-4-phosphatase, type I 1.33 0.00 1.36 0.00 NA NA 
31 Lpin1 lipin 1 1.35 0.02 1.44 0.09 NA NA 
32 Kif21a kinesin family member 21A 1.36 0.00 1.40 0.02 NA NA 
33 Hpca hippocalcin 1.37 0.01 1.44 0.03 NA NA 
34 Fam126b 
family with sequence 
similarity 126, member 
B 
1.37 0.01 1.46 0.04 NA NA 
35 Nlrp12 NLR family, pyrin domain containing 12 1.40 0.00 1.50 0.03 NA NA 
36 Sra1 steroid receptor RNA activator 1 1.42 0.00 1.52 0.02 NA NA 
37 Cd80 CD80 antigen 1.45 0.02 1.69 0.08 NA NA 
38 Gata4 GATA binding protein 4 1.45 0.01 1.63 0.03 NA NA 
39 Jmy junction-mediating and regulatory protein 1.47 0.00 1.52 0.00 NA NA 
40 Trpv4 
transient receptor 
potential cation channel, 
subfamily V, member 4 
1.48 0.01 1.70 0.03 NA NA 
41 Ccng2 cyclin G2 1.50 0.00 1.62 0.00 NA NA 
42 Cobll1 Cobl-like 1 1.51 0.00 1.57 0.00 NA NA 
43 Pfkfb3 
6-phosphofructo-2-
kinase/fructose-2,6-
biphosphatase 3 
1.53 0.00 1.61 0.00 NA NA 
44 Tiparp 
TCDD-inducible 
poly(ADP-ribose) 
polymerase 
1.53 0.00 1.71 0.01 NA NA 
45 Fkbp5 FK506 binding protein 5 1.56 0.00 1.82 0.01 NA NA 
46 Josd1 Josephin domain containing 1 1.64 0.00 NA NA 2.03 0.10 
47 Btg2 B cell translocation gene 2, anti-proliferative 1.64 0.00 NA NA 2.16 0.06 
48 Tubb2a tubulin, beta 2A class IIA 1.69 0.00 2.35 0.01 NA NA 
49 Fbxo31 F-box protein 31  1.75 0.00 NA NA 1.98 0.08 
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Note: Fold change (FC) discussed was taken from the DESeq2 analysis which was the 
most conservative. False discovery rate (FDR) was calculated with a Benjamini-
Hochberg correction.  
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Supplementary Table 4.3.4 Function of hypoxia-inducible genes differentially 
expressed in MNR offspring. 
Gene Symbol Role in HIF signalling Functions References 
Vhl Negative regulator of Hif-1a and 
Hif-2a  
U3 ubiquitin ligase complex (1) 
Mll1 Transcriptional co-activator at 
HRE-containing genes 
H3K4 Histone demethyltransferase (2) 
Chrna4 Neuronal acetylcholine receptors 
promote accumulation and 
stability of Hif-1a 
Nicotine receptor (3) 
Rassf1 Upregulated with hypoxia and 
HIF1/2a expression 
Tumor suppressor (4,5) 
Jmy Hypoxia-induced HRE-
containing gene 
Actin polymerization (6) 
Nrp12 Transcriptionally downregulated 
by HIF-1a 
Receptor, ligands include VEGF (7) 
CD80 Reduction on myeloid cells in 
response to hypoxia 
Stimulates T-cell innate immunity (8) 
Ccng2 Hypoxia-induced HRE-
containing gene 
Negative cell cycle 
regulation/regulation of the 
cytoskeleton 
(9,10) 
Maff Hypoxia-induced HRE-
containing gene 
Transcriptional regulator (5,11) 
Angptl4 Hypoxia-induced HRE-
containing gene 
Secreted protein involved in 
angiogenesis and is a negative 
regulator of lipoprotein lipase 
(12–14) 
Btg2 Hypoxia-induced Hif-1a 
dependent transcription 
Negative cell cycle regulation (15) 
Fkbp5 Hypoxia-induced gene 
potentially via HIF-2a inhibition 
of AR, and as a KDM3a target 
Co-chaperon and scaffold protein (5,16,17) 
Pfkfb3 Hypoxia-induced HRE-
containing gene 
Phosphatase and diphosphatase to 
fructose-2,6-bisphosphotate 
(5,18) 
Kdm3a Hypoxia-induced HRE-
containing gene and is recruited 
to promoters of HRE-containing 
genes 
H3K9 histone demethylase (5,14) 
Hif-3a Induced by HIF-1a and a 
negative regulator of HIF-
induced transcription 
Transcriptional regulator (19,20) 
Ppp1r15a Hypoxia-induced HRE-
containing gene 
Unfolded protein response reducing 
protein synthesis 
(5,21) 
Cited2 Prevents CBP/P300 binding 
inhibiting HIF-1a transactivation 
Transcriptional regulator (22) 
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Appendix 3 
Chapter 5 Supplementary Figures 
 
Supplementary Figure S5.2.1 Biplots of controls (A), intolerant MNR (B) and 
tolerant MNR (C) in liver RNAseq data.  
One sample in the tolerant MNR (red box) contributed more variation to the group than 
any other samples and was removed from further analysis.  
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Supplementary Figure S5.2.2 Biplots of controls (A), intolerant MNR (B) and 
tolerant MNR (C) muscle RNA sequencing data.  
One control and one intolerant MNR (red box) contributed more variation to the group 
than any other samples with the group. Outliers were removed from further analysis.  
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Supplementary Figure S5.2.3 Biplots of sequenced RNA from adipose tissue of 
controls (A), intolerant MNR (B) and tolerant MNR (C). 
 One sample from each group (red box) contributed more variation to the group than any 
other samples with the group and were removed from further analysis.
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Supplementary Figure S5.2.4 Fasting blood glucose of 6-month-old control and 
MNR offspring.  
Fasting blood glucose was similar for control (6.5 ± 0.3 mmol/L) and MNR (7.3 ± 0.3 
mmol/L) offspring (p = 0.2), however, 4 MNR had a higher fasting blood glucose than 
any controls (as indicate by the box). Data are expressed as mean ± SEM and compared 
with a Mann-Whitney test.
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Supplementary Figure S5.3.1 PCA of top 500 variable genes in RNAseq data of the 
liver, adipose tissue, and skeletal muscle of 6-month-old MNR offspring. Samples 
clustered based on tissue (colour) but not maternal nutrition (symbol).  
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Supplementary Table 5.3.1 Differentially expressed genes (0.1 >FDR, Fold change 
[FC] ³ 2, 2 or more tools) in liver, skeletal muscle and adipose tissue of 6-month-old 
offspring. 
Tissue Reference Comparison 
Group 
Gene ID Gene Name Ave. 
FC 
Ave. 
FDR 
Tools 
Liver Control MNR Alas1 aminolevulinic acid synthase 
1 [Source:MGI 
Symbol;Acc:MGI:87989] 
-2.69 0.045 DESeq2. 
EdgeR. 
Aldex2 
Hspa1l heat shock protein 1-like 
[Source:MGI 
Symbol;Acc:MGI:96231] 
-2.43 0.027 DESeq2. 
EdgeR. 
Aldex2 
Hspb1 heat shock protein 1 
[Source:MGI 
Symbol;Acc:MGI:96240] 
-2.14 0.085 DESeq2. 
EdgeR. 
Aldex2 
Fgf11 fibroblast growth factor 11 
[Source:MGI 
Symbol;Acc:MGI:109167] 
-2.06 0.062 DESeq2. 
EdgeR. 
Aldex2 
Rfx4 regulatory factor X, 4 
(influences HLA class II 
expression) [Source:MGI 
Symbol;Acc:MGI:1918387] 
2.21 0.049 DESeq2. 
EdgeR 
Trem2 triggering receptor expressed 
on myeloid cells 2 
[Source:MGI 
Symbol;Acc:MGI:1913150] 
2.22 0.004 DESeq2. 
EdgeR 
Control Intolerant 
MNR 
Hspa1a heat shock protein 1A 
[Source:MGI 
Symbol;Acc:MGI:96244] 
-3.54 0.002 DESeq2. 
EdgeR 
Hspa1l heat shock protein 1-like 
[Source:MGI 
Symbol;Acc:MGI:96231] 
-3.36 0.001 DESeq2. 
EdgeR 
Alas1 aminolevulinic acid synthase 
1 [Source:MGI 
Symbol;Acc:MGI:87989] 
-3.25 0.011 DESeq2. 
EdgeR 
Hspa1b heat shock protein 1B 
[Source:MGI 
Symbol;Acc:MGI:99517] 
-3.14 0.004 DESeq2. 
EdgeR 
Dnaic1 dynein, axonemal, 
intermediate chain 1 
[Source:MGI 
Symbol;Acc:MGI:1916172] 
-2.94 0.059 DESeq2. 
EdgeR 
Hspb1 heat shock protein 1 
[Source:MGI 
Symbol;Acc:MGI:96240] 
-2.63 0.022 DESeq2. 
EdgeR 
Eif4ebp3 eukaryotic translation 
initiation factor 4E binding 
protein 3 [Source:MGI 
Symbol;Acc:MGI:1270847] 
-2.45 0.006 DESeq2. 
EdgeR 
Saa1 serum amyloid A 1 
[Source:MGI 
Symbol;Acc:MGI:98221] 
-2.44 0.047 DESeq2. 
EdgeR 
Grem2 gremlin 2 homolog, cysteine 
knot superfamily (Xenopus 
laevis) [Source:MGI 
Symbol;Acc:MGI:1344367] 
-2.37 0.047 DESeq2. 
EdgeR 
Pcp4l1 Purkinje cell protein 4-like 1 
[Source:MGI 
-2.19 0.000 DESeq2. 
EdgeR 
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Symbol;Acc:MGI:1913675] 
Tbc1d30 TBC1 domain family, 
member 30 [Source:MGI 
Symbol;Acc:MGI:1921944] 
-2.09 0.001 DESeq2. 
EdgeR 
Cyp26b1 cytochrome P450, family 26, 
subfamily b, polypeptide 1 
[Source:MGI 
Symbol;Acc:MGI:2176159] 
-2.07 0.056 DESeq2. 
EdgeR 
Fgf11 fibroblast growth factor 11 
[Source:MGI 
Symbol;Acc:MGI:109167] 
-2.04 0.089 DESeq2. 
EdgeR 
Ank3 ankyrin 3, epithelial 
[Source:MGI 
Symbol;Acc:MGI:88026] 
2.03 0.001 DESeq2. 
EdgeR 
Gdf15 growth differentiation factor 
15 [Source:MGI 
Symbol;Acc:MGI:1346047] 
2.03 0.065 DESeq2. 
EdgeR 
Trem2 triggering receptor expressed 
on myeloid cells 2 
[Source:MGI 
Symbol;Acc:MGI:1913150] 
2.04 0.008 DESeq2. 
EdgeR 
Gngt1 guanine nucleotide binding 
protein (G protein), gamma 
transducing activity 
polypeptide 1 [Source:MGI 
Symbol;Acc:MGI:109165] 
2.06 0.062 DESeq2. 
EdgeR 
Vldlr very low density lipoprotein 
receptor [Source:MGI 
Symbol;Acc:MGI:98935] 
2.13 0.056 DESeq2. 
EdgeR 
Rfx4 regulatory factor X, 4 
(influences HLA class II 
expression) [Source:MGI 
Symbol;Acc:MGI:1918387] 
2.20 0.012 DESeq2. 
EdgeR 
Raet1d retinoic acid early transcript 
delta [Source:MGI 
Symbol;Acc:MGI:1861032] 
2.38 0.050 DESeq2. 
EdgeR 
Pdk4 pyruvate dehydrogenase 
kinase, isoenzyme 4 
[Source:MGI 
Symbol;Acc:MGI:1351481] 
2.65 0.001 DESeq2. 
EdgeR 
Adcy1 adenylate cyclase 1 
[Source:MGI 
Symbol;Acc:MGI:99677] 
4.10 0.039 DESeq2. 
EdgeR 
Ntrk2 neurotrophic tyrosine kinase, 
receptor, type 2 [Source:MGI 
Symbol;Acc:MGI:97384] 
4.90 0.000 DESeq2. 
EdgeR 
Cyp2b9 cytochrome P450, family 2, 
subfamily b, polypeptide 9 
[Source:MGI 
Symbol;Acc:MGI:88600] 
7.03 0.063 DESeq2. 
EdgeR 
Control Impaired 
fasting blood 
glucose 
ccl21c C-C motif chemokine 21c  
[Source:UniProtKB/Swiss-
Prot;Acc:P86793] 
-6.32 0.022 DESeq2. 
EdgeR 
Cyp26b1 cytochrome P450, family 26, 
subfamily b, polypeptide 1 
[Source:MGI 
Symbol;Acc:MGI:2176159] 
-5.16 0.000 DESeq2. 
EdgeR 
Mfsd2a major facilitator superfamily 
domain containing 2A 
[Source:MGI 
Symbol;Acc:MGI:1923824] 
-4.74 0.004 DESeq2. 
EdgeR 
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Cyp2b10 cytochrome P450, family 2, 
subfamily b, polypeptide 10 
[Source:MGI 
Symbol;Acc:MGI:88598] 
-2.93 0.001 DESeq2. 
EdgeR 
Serpina12 serine (or cysteine) peptidase 
inhibitor, clade A (alpha-1 
antiproteinase, antitrypsin), 
member 12 [Source:MGI 
Symbol;Acc:MGI:1915304] 
-2.19 0.015 DESeq2. 
EdgeR 
Adarb2 adenosine deaminase, RNA-
specific, B2 [Source:MGI 
Symbol;Acc:MGI:2151118] 
2.29 0.016 DESeq2. 
EdgeR 
Epha5 Eph receptor A5 
[Source:MGI 
Symbol;Acc:MGI:99654] 
2.62 0.065 DESeq2. 
EdgeR 
Tolerant 
MNR 
Intolerant 
MNR 
mt1 metallothionein 1 2.47 0.057 DESeq2. 
EdgeR 
Muscle Control MNR NA NA NA NA NA 
Control Intolerant 
MNR 
Gdpd3 glycerophosphodiester 
phosphodiesterase domain 
containing 3 [Source:MGI 
Symbol;Acc:MGI:1915866] 
-5.78 0.071 DESeq2. 
EdgeR 
Il1f9 interleukin 1 family, member 
9 [Source:MGI 
Symbol;Acc:MGI:2449929] 
-3.59 0.013 DESeq2. 
EdgeR 
Cyp1b1 cytochrome P450, family 1, 
subfamily b, polypeptide 1 
[Source:MGI 
Symbol;Acc:MGI:88590] 
-2.34 0.028 DESeq2. 
EdgeR 
Control Impaired 
fasting blood 
glucose 
Nr4a3 nuclear receptor subfamily 4, 
group A, member 3 
[Source:MGI 
Symbol;Acc:MGI:1352457] 
-4.54 0.050 DESeq2. 
EdgeR 
Slc25a25 solute carrier family 25 
(mitochondrial carrier, 
phosphate carrier), member 
25 [Source:MGI 
Symbol;Acc:MGI:1915913] 
-2.81 0.040 DESeq2. 
EdgeR 
Irs2 insulin receptor substrate 2 
[Source:MGI 
Symbol;Acc:MGI:109334] 
-2.80 0.025 DESeq2. 
EdgeR 
Panx1 pannexin 1 [Source:MGI 
Symbol;Acc:MGI:1860055] 
2.08 0.014 DESeq2. 
EdgeR 
Tolerant 
MNR 
Intolerant 
MNR 
Kcna6 potassium voltage-gated 
channel, shaker-related, 
subfamily, member 6 
[Source:MGI 
Symbol;Acc:MGI:96663] 
2.31 0.061 DESeq2. 
EdgeR 
Adipose 
tissue 
Control MNR Napsa napsin A aspartic peptidase 
[Source:MGI 
Symbol;Acc:MGI:109365] 
-
172.97 
0.012 DESeq2. 
EdgeR 
Control Intolerant 
MNR 
Cox8a cytochrome c oxidase, 
subunit VIIIa [Source:MGI 
Symbol;Acc:MGI:105959] 
2.30 0.038 DESeq2. 
EdgeR 
Zcchc24 zinc finger, CCHC domain 
containing 24 [Source:MGI 
Symbol;Acc:MGI:1919168] 
2.35 0.067 DESeq2. 
EdgeR 
Inpp5d inositol polyphosphate-5-
phosphatase D [Source:MGI 
Symbol;Acc:MGI:107357] 
2.70 0.032 DESeq2. 
EdgeR 
Vwa1 von Willebrand factor A 2.84 0.079 DESeq2. 
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domain containing 1 
[Source:MGI 
Symbol;Acc:MGI:2179729] 
EdgeR 
Timp4 tissue inhibitor of 
metalloproteinase 4 
[Source:MGI 
Symbol;Acc:MGI:109125] 
3.43 0.020 DESeq2. 
EdgeR 
Gcnt1 glucosaminyl (N-acetyl) 
transferase 1, core 2 
[Source:MGI 
Symbol;Acc:MGI:95676] 
3.56 0.052 DESeq2. 
EdgeR 
  Xlr3b X-linked lymphocyte-
regulated 3B 
-2.09 0.019 DESeq2. 
EdgeR 
Lrriq3  leucine-rich repeats and IQ 
motif containing 3 
-2.02 0.032 DESeq2. 
EdgeR 
Napsa napsin A aspartic peptidase 
[Source:MGI 
Symbol;Acc:MGI:109365] 
1.96 0.001 DESeq2. 
EdgeR 
  NA NA NA NA NA 
Note: Fold change (FC) and false discovery rate (FDR) are expressed as an average 
between to the differential expression tools. 
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